UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
☒ QUARTERLY REPORT PURSUANT TO SECTION
13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30,
2024
☐ TRANSITION REPORT PURSUANT TO SECTION 13
OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _________________
to _______________________
Commission File number: 001-41432
SK Growth Opportunities Corporation
(Exact name of registrant as specified in its
charter)
Cayman Islands | | 001-41432 | | 98-1643582 |
(State or other jurisdiction of
incorporation or organization) | | (Commission File Number) | | (I.R.S. Employer
Identification Number) |
228 Park Avenue S #96693 New York, New York | | 10003 |
(Address of principal executive offices) | | (Zip Code) |
(917) 599-1622
(Registrant’s telephone number, including
area code)
Not Applicable |
(Former name or former address, if changed since last report) |
Securities registered pursuant to Section 12(b)
of the Act:
Title of each class | | Trading Symbol(s) | | Name of each exchange on which registered |
Units, each consisting of one Class A Ordinary Share, $0.0001 par value, and one-half of one redeemable warrant | | SKGRU | | The Nasdaq Stock Market LLC |
Class A Ordinary Shares | | SKGR | | The Nasdaq Stock Market LLC |
Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 | | SKGRW | | The Nasdaq Stock Market LLC |
Indicate by check mark whether
the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether
the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T
(§232.405of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such
files). Yes ☒ No ☐
Indicate by check mark whether
the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging
growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting
company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | ☐ | Accelerated filer | ☐ |
| Non-accelerated filer | ☒ | Smaller reporting company | ☒ |
| | | Emerging growth company | ☒ |
If an emerging growth company,
indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark
whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐
As of November 13, 2024,
there were 9,732,960 shares of the registrant’s Class A ordinary shares, par value $0.0001 per share, and 5,240,000 shares of the
registrant’s Class B ordinary shares, par value $0.0001 per share, issued and outstanding.
SK GROWTH OPPORTUNITIES CORPORATION
TABLE OF CONTENTS
PART I-FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
SK GROWTH OPPORTUNITIES CORPORATION
CONDENSED BALANCE SHEETS
| |
September 30, 2024 | | |
December 31, 2023 | |
Assets: | |
(unaudited) | | |
| |
Current assets: | |
| | |
| |
Cash | |
$ | 621,449 | | |
$ | 163,718 | |
Prepaid expenses | |
| 27,750 | | |
| 209,750 | |
Total current assets | |
| 649,199 | | |
| 373,468 | |
| |
| | | |
| | |
Investments held in Trust Account | |
| 113,898,350 | | |
| 109,573,279 | |
Total Assets | |
$ | 114,547,549 | | |
$ | 109,946,747 | |
| |
| | | |
| | |
Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit: | |
| | | |
| | |
Current liabilities: | |
| | | |
| | |
Accounts payable | |
$ | 10,525 | | |
$ | 107,223 | |
Accrued expenses | |
| 2,084,183 | | |
| 1,204,161 | |
Extension payment payable | |
| 279,489 | | |
| — | |
Sponsor Note | |
| 1,720,000 | | |
| 380,000 | |
Ordinary Class A shares to be redeemed | |
| 3,663,464 | | |
| — | |
Total current liabilities | |
| 7,757,661 | | |
| 1,691,384 | |
| |
| | | |
| | |
Non-current liabilities: | |
| | | |
| | |
Overfunding loan | |
| 5,240,000 | | |
| 5,240,000 | |
Deferred underwriting and advisory fees | |
| 7,336,000 | | |
| 7,336,000 | |
Total non-current liabilities | |
| 12,576,000 | | |
| 12,576,000 | |
Total liabilities | |
| 20,333,661 | | |
| 14,267,384 | |
| |
| | | |
| | |
Commitments and Contingencies | |
| | | |
| | |
Class A ordinary shares, $0.0001 par value; 9,000,000,000 shares authorized; 9,732,960 and 10,056,597 shares subject to possible redemption at approximately $11.32 and $10.89 per share as of September 30, 2024 and December 31, 2023, respectively | |
| 110,134,886 | | |
| 109,473,279 | |
| |
| | | |
| | |
Shareholders’ Deficit: | |
| | | |
| | |
Preference shares, $0.0001 par value; 990,000 shares authorized; none issued or outstanding as of September 30, 2024 and December 31, 2023 | |
| — | | |
| — | |
Class A ordinary shares, $0.0001 par value; 9,000,000,000 shares authorized; no non-redeemable shares issued or outstanding (excluding 9,732,960 shares subject to possible redemption) as of September 30, 2024 and December 31, 2023 | |
| — | | |
| — | |
Class B ordinary shares, $0.0001 par value; 999,000,000 shares authorized; 5,240,000 shares issued and outstanding as of September 30, 2024 and December 31, 2023 | |
| 524 | | |
| 524 | |
Additional paid-in capital | |
| — | | |
| — | |
Accumulated deficit | |
| (15,921,522 | ) | |
| (13,794,440 | ) |
Total shareholders’ deficit | |
| (15,920,998 | ) | |
| (13,793,916 | ) |
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit | |
$ | 114,547,549 | | |
$ | 109,946,747 | |
The accompanying notes are an integral part
of the unaudited condensed financial statements.
SK GROWTH OPPORTUNITIES CORPORATION
UNAUDITED CONDENSED STATEMENTS OF OPERATIONS
| |
For the Three Months Ended September 30, | | |
For the Nine Months Ended September 30, | |
| |
2024 | | |
2023 | | |
2024 | | |
2023 | |
General and administrative expenses | |
$ | 340,283 | | |
$ | 1,023,103 | | |
$ | 2,127,082 | | |
$ | 1,572,320 | |
Loss from operations | |
| (340,283 | ) | |
| (1,023,103 | ) | |
| (2,127,082 | ) | |
| (1,572,320 | ) |
| |
| | | |
| | | |
| | | |
| | |
Other income: | |
| | | |
| | | |
| | | |
| | |
Income from investments held in Trust Account | |
| 1,457,119 | | |
| 2,875,342 | | |
| 4,325,071 | | |
| 7,633,712 | |
Total other income | |
| 1,457,119 | | |
| 2,875,342 | | |
| 4,325,071 | | |
| 7,633,712 | |
| |
| | | |
| | | |
| | | |
| | |
Net income | |
$ | 1,116,836 | | |
$ | 1,852,239 | | |
$ | 2,197,989 | | |
$ | 6,061,392 | |
| |
| | | |
| | | |
| | | |
| | |
Basic and diluted weighted average shares outstanding, Class A ordinary shares | |
| 10,042,526 | | |
| 20,960,000 | | |
| 10,051,872 | | |
| 20,960,000 | |
Basic and diluted net income per share, Class A ordinary shares | |
$ | 0.07 | | |
$ | 0.07 | | |
$ | 0.14 | | |
$ | 0.23 | |
| |
| | | |
| | | |
| | | |
| | |
Basic and diluted weighted average shares outstanding, Class B ordinary shares | |
| 5,240,000 | | |
| 5,240,000 | | |
| 5,240,000 | | |
| 5,240,000 | |
Basic and diluted net income per share, Class B ordinary shares | |
$ | 0.07 | | |
$ | 0.07 | | |
$ | 0.14 | | |
$ | 0.23 | |
The accompanying notes are an integral part
of the unaudited condensed financial statements.
SK GROWTH OPPORTUNITIES CORPORATION
UNAUDITED CONDENSED STATEMENTS OF CHANGES IN
SHAREHOLDERS’ DEFICIT
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER
30, 2024
| |
Class B | | |
Additional | | |
| | |
Total | |
| |
Ordinary Shares | | |
Paid-in | | |
Accumulated | | |
Shareholders’ | |
| |
Shares | | |
Amount | | |
Capital | | |
Deficit | | |
Deficit | |
Balance—December 31, 2023 | |
| 5,240,000 | | |
$ | 524 | | |
$ | — | | |
$ | (13,794,440 | ) | |
$ | (13,793,916 | ) |
Accretion for Class A ordinary shares to redemption amount | |
| — | | |
| — | | |
| — | | |
| (1,427,435 | ) | |
| (1,427,435 | ) |
Net loss | |
| — | | |
| — | | |
| — | | |
| (122,621 | ) | |
| (122,621 | ) |
Balance—March 31, 2024 | |
| 5,240,000 | | |
$ | 524 | | |
$ | — | | |
$ | (15,344,496 | ) | |
$ | (15,343,972 | ) |
Accretion for Class A ordinary shares to redemption amount | |
| — | | |
| — | | |
| — | | |
| (1,440,517 | ) | |
| (1,440,517 | ) |
Net income | |
| — | | |
| — | | |
| — | | |
| 1,203,774 | | |
| 1,203,774 | |
Balance—June 30, 2024 | |
| 5,240,000 | | |
$ | 524 | | |
$ | — | | |
$ | (15,581,239 | ) | |
$ | (15,580,715 | ) |
Accretion for Class A ordinary shares to redemption amount | |
| — | | |
| — | | |
| — | | |
| (1,457,119 | ) | |
| (1,457,119 | ) |
Net income | |
| — | | |
| — | | |
| — | | |
| 1,116,836 | | |
| 1,116,836 | |
Balance—September 30, 2024 | |
| 5,240,000 | | |
$ | 524 | | |
$ | — | | |
$ | (15,921,522 | ) | |
$ | (15,920,998 | ) |
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER
30, 2023
| |
Class B | | |
Additional | | |
| | |
Total | |
| |
Ordinary Shares | | |
Paid-in | | |
Accumulated | | |
Shareholders’ | |
| |
Shares | | |
Amount | | |
Capital | | |
Deficit | | |
Deficit | |
Balance —December 31, 2022 | |
| 5,240,000 | | |
$ | 524 | | |
$ | — | | |
$ | (11,643,310 | ) | |
$ | (11,642,786 | ) |
Accretion for Class A ordinary shares to redemption amount | |
| — | | |
| — | | |
| — | | |
| (2,300,710 | ) | |
| (2,300,710 | ) |
Net income | |
| — | | |
| — | | |
| — | | |
| 2,008,659 | | |
| 2,008,659 | |
Balance — March 31, 2023 | |
| 5,240,000 | | |
| 524 | | |
$ | — | | |
| (11,935,361 | ) | |
| (11,934,837 | ) |
Accretion for Class A ordinary shares to redemption amount | |
| — | | |
| — | | |
| — | | |
| (2,457,660 | ) | |
| (2,457,660 | ) |
Net income | |
| — | | |
| — | | |
| — | | |
| 2,200,494 | | |
| 2,200,494 | |
Balance — June 30, 2023 | |
| 5,240,000 | | |
$ | 524 | | |
$ | — | | |
$ | (12,192,527 | ) | |
$ | (12,192,003 | ) |
Accretion for Class A ordinary shares to redemption amount | |
| — | | |
| — | | |
| — | | |
| (2,875,342 | ) | |
| (2,875,342 | ) |
Net income | |
| — | | |
| — | | |
| — | | |
| 1,852,239 | | |
| 1,852,239 | |
Balance — September 30, 2023 | |
| 5,240,000 | | |
$ | 524 | | |
$ | — | | |
$ | (13,215,630 | ) | |
$ | (13,215,106 | ) |
The accompanying notes are an integral part
of the unaudited condensed financial statements.
SK GROWTH OPPORTUNITIES CORPORATION
UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS
| |
For the Nine Months Ended September 30, | |
| |
2024 | | |
2023 | |
Cash Flows from Operating Activities: | |
| | |
| |
Net income | |
$ | 2,197,989 | | |
$ | 6,061,392 | |
Adjustments to reconcile net income to net cash used in operating activities: | |
| | | |
| | |
General and administrative expenses paid by related party under promissory note | |
| 256,000 | | |
| — | |
Income from investments held in Trust Account | |
| (4,325,071 | ) | |
| (7,633,712 | ) |
Changes in operating assets and liabilities: | |
| | | |
| | |
Prepaid expenses | |
| 182,000 | | |
| 288,191 | |
Accounts payable | |
| (96,698 | ) | |
| 155,000 | |
Accrued expenses | |
| 880,022 | | |
| 686,413 | |
Extension payment payable | |
| 279,489 | | |
| — | |
Net cash used in operating activities | |
| (626,269 | ) | |
| (442,716 | ) |
| |
| | | |
| | |
Cash Flows from Financing Activities: | |
| | | |
| | |
Proceeds from promissory note | |
| 1,084,000 | | |
| — | |
Net cash provided by financing activities | |
| 1,084,000 | | |
| — | |
| |
| | | |
| | |
Net change in cash | |
| 457,731 | | |
| (442,716 | ) |
Cash—beginning of the period | |
| 163,718 | | |
| 515,410 | |
Cash—end of the period | |
$ | 621,449 | | |
$ | 72,694 | |
| |
| | | |
| | |
Non-cash financing activities: | |
| | | |
| | |
General and administrative expenses paid by Sponsor under promissory note | |
$ | 256,000 | | |
$ | — | |
Ordinary Class A shares to be redeemed | |
$ | 3,663,464 | | |
$ | — | |
The accompanying notes are an integral part
of the unaudited condensed financial statements.
SK GROWTH OPPORTUNITIES CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2024
Note 1—Description of Organization, Business
Operations, Liquidity and Basis of Presentation
SK Growth Opportunities Corporation (the “Company”)
is a blank check company incorporated in Cayman Islands on December 8, 2021. The Company was formed for the purpose of effecting
a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies.
As of September 30, 2024, the Company had not
commenced any operations. All activity for the period from December 8, 2021 (inception) through September 30, 2024, relates to the
Company’s formation and the initial public offering (the “Initial Public Offering”) described below, and since the Initial
Public Offering, its search for a Business Combination (as defined below). The Company will not generate any operating revenues until
after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest
income from the proceeds held in the Trust Account (as defined below).
The Company’s sponsor is Auxo Capital Managers
LLC, a Delaware limited liability company (the “Sponsor”). The registration statement for the Company’s Initial Public
Offering was declared effective on June 23, 2022. On June 28, 2022, the Company consummated its Initial Public Offering of 20,000,000 units
(the “Units” and, with respect to the Class A ordinary shares included in the Units, the “Public Shares”),
at $10.00 per Unit, generating gross proceeds of $200.0 million, and incurring offering costs of approximately $12.0 million,
of which $7.0 million was for deferred underwriting commissions (see Note 5). The underwriter was granted a 45-day option from
the date of the final prospectus relating to the Initial Public Offering to purchase up to 3,000,000 additional Units to cover
over-allotments, if any, at $10.00 per Unit (the “Over-Allotment Option”). On July 20, 2022, pursuant to the underwriter’s
notice of the partial exercise of the Over-Allotment Option, the Company sold an additional 960,000 Units, at $10.00 per Unit,
generating aggregate additional gross proceeds of $9.6 million to the Company (the “Partial Over-Allotment Exercise”).
On August 9, 2022, following the expiration of the remaining Over-Allotment Option, the Sponsor forfeited 510,000 Founder Shares (as
defined in Note 4).
Simultaneously with the closing of the Initial
Public Offering, the Company consummated the private placement (“Private Placement”) of 6,600,000 warrants of the Company
(each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”), at a price of $1.00
per Private Placement Warrant in a private placement to the Sponsor, generating proceeds of $6.6 million (see Note 4). Substantially
concurrently with the closing of the Partial Over-Allotment Exercise, the Company completed the sale of 192,000 additional Private Placement
Warrants to the Sponsor (the “Additional Private Placement”) at a purchase price of $1.00 per Private Placement Warrant, generating
gross proceeds to the Company of $192,000.
In addition, upon the consummation of the Initial
Public Offering on June 28, 2022, the Sponsor provided the Company with the First Overfunding Loan (as defined in Note 4) in the
amount of $5.0 million to deposit in the Trust Account at no interest. In connection with the Partial Over-Allotment Exercise on
July 20, 2022, the Sponsor provided the Company with the Second Overfunding Loan (as defined in Note 4) in the amount of $240,000 to
deposit in the Trust Account.
Upon the closing of the Initial Public Offering
and the Partial Over-Allotment Exercise, approximately $214.8 million ($10.25 per Unit) of net proceeds, including
the net proceeds of the Initial Public Offering, the Partial Over-Allotment Exercise the proceeds of the Overfunding Loans and certain
of the proceeds of the Private Placement and the Additional Private Placement, was placed in a trust account (the “Trust Account”)
located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and invested only in United States
“government securities” within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended
(the “Investment Company Act”) having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment
Company Act which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of (i) the
completion of a Business Combination and (ii) the distribution of the Trust Account as described below.
The Company’s management has broad discretion
with respect to the specific application of the net proceeds of the Initial Public Offering, the sale of Private Placement Warrants and
the proceeds from the Overfunding Loan, although substantially all of the net proceeds are intended to be applied generally toward consummating
a Business Combination. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at
least 80% of the net assets held in the Trust Account (excluding the amount of deferred underwriting discounts held in Trust and
taxes payable on the income earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination.
However, the Company only intends to complete a Business Combination if the post-transaction company owns or acquires 50% or more
of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for
it not to be required to register as an investment company under the Investment Company Act.
SK GROWTH OPPORTUNITIES CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2024
The Company will provide the holders of the Company’s
Public Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the
completion of a Business Combination either (i) in connection with a shareholders meeting called to approve the Business Combination
or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination
or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their
Public Shares for a pro rata portion of the amount then held in the Trust Account (initially at $10.25 per Public Share). The per-share
amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions
the Company will pay to the underwriter (as discussed in Note 5).
The Public Shares are recognized at redemption
value and classified as temporary equity, in accordance with the Financial Accounting Standards Board (“FASB”) Accounting
Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity” (“ASC 480”). The
Company will proceed with a Business Combination if a majority of the shares voted are voted in favor of the Business Combination. If
a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other legal reasons,
the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association (the “Articles of Association”),
conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file
tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transaction is
required by law, or the Company decides to obtain shareholder approval for business or legal reasons, the Company will offer to redeem
the Public Shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally,
each Public Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction.
If the Company seeks shareholder approval in connection with a Business Combination, the initial shareholders (as defined below) agreed
to vote their Founder Shares and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination.
In addition, the initial shareholders agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in
connection with the completion of a Business Combination.
The Articles of Association provides that a Public
Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as
a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)),
will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares included in the Units
issued in the Company’s Initial Public Offering, without the prior consent of the Company. The holders of the Founder Shares (the
“initial shareholders”) agreed not to propose an amendment to the Articles of Association (A) to modify the substance
or timing of the Company’s obligation to allow redemption in connection with a Business Combination or to redeem 100% of the Public
Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (B) with respect
to any other material provisions relating to shareholders’ rights or pre-initial Business Combination activity, unless the Company
provides the Public Shareholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.
On December 27, 2023, the Company held an
extraordinary general meeting of shareholders (the “First Extension Meeting”), to (i) amend the Company’s amended
and restated memorandum and articles of association (the “Memorandum and Articles of Association”) to extend the date by which
the Company has to consummate a business combination from December 28, 2023 to September 30, 2024 (or March 31, 2025) as the
Company’s board of directors (the “Board”) may approve in accordance with the Memorandum and Articles of Association
(such amendment, the “First Articles Amendment” and such proposal, the “First Extension Amendment Proposal”),
(ii) amend the Investment Management Trust Agreement, dated June 23, 2022, by and between the Company and Continental, to extend
the date on which Continental must liquidate the Trust Account if the Company has not completed its initial business combination, from
December 28, 2023 to September 30, 2024 (or March 31, 2025) as the Board may approve (the “First Trust Amendment Proposal”).
The First Extension Amendment Proposal and the First Trust Amendment Proposal were approved. In connection with the vote to approve the
First Articles Amendment, the holders of 10,903,403 Class A Ordinary Shares of the Company properly exercised their right to redeem
their shares for cash at a redemption price of approximately $10.88 per share, for an aggregate redemption amount of approximately $118,642,864.
On September 27, 2024, the Company held an extraordinary general meeting
of shareholders (the “Second Extension Meeting”), to (i) amend the Memorandum and Articles of Association to extend the
date by which the Company has to consummate a business combination from September 30, 2024 to March 31, 2025 (such amendment, the
“Second Articles Amendment” and such proposal, the “Second Extension Amendment Proposal”), (ii) amend the Investment
Management Trust Agreement, dated June 23, 2022, by and between the Company and Continental, to extend the date on which Continental
must liquidate the Trust Account if the Company has not completed its initial business combination, from September 30, 2024 to March
31, 2025 (the “Second Trust Amendment Proposal”). The Sponsor has agreed that if the Second Extension Amendment Proposal is
approved and implemented, it or its designee will contribute to the Company, as a loan, $0.03 for each Public Share that is not redeemed
in connection with the Second Extension Amendment Proposal for each calendar month (commencing on October 1, 2024 and on the 1st day of
each subsequent month) until March 31, 2025, or portion thereof, that is needed to complete the Business Combination. The Second Extension
Amendment Proposal and the Second Trust Amendment Proposal were approved. In connection with the vote to approve the Second Articles Amendment,
the holders of 323,637 Class A Ordinary Shares of the Company properly exercised their right to redeem their shares for cash at a redemption
price of approximately $11.32 per share, for an aggregate redemption amount of approximately $3,663,464.
SK GROWTH OPPORTUNITIES CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2024
If the Company is unable to consummate an initial
Business Combination prior to March 31, 2025 (such period, the “Combination Period”), the Company will (i) cease all
operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter,
redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including
interest earned on the funds held in the Trust Account (less taxes payable and up to $100,000 of interest to pay dissolution expenses)
divided by the number of the then-outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights
as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible
following such redemption, subject to the approval of the remaining shareholders and the board of directors, liquidate and dissolve, subject
in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other
applicable law.
The initial shareholders agreed to waive their
rights to liquidating distributions from the Trust Account with respect to the Founder Shares if the Company fails to complete a Business
Combination within the Combination Period. However, if the initial shareholders acquire Public Shares in or after the Initial Public Offering,
they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete
a Business Combination within the Combination Period. The underwriter agreed to waive its rights to the deferred underwriting commission
(see Note 5) held in the Trust Account in the event the Company does not complete a Business Combination within in the Combination Period
and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption
of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available
for distribution (including Trust Account assets) will be only $10.25. In order to protect the amounts held in the Trust Account, the
Sponsor agreed to be liable to the Company if and to the extent any claims by a third party (except for the Company’s independent
registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which
the Company has discussed entering into a transaction agreement (a “Target”), reduce the amount of funds in the Trust Account
to below (i) $10.25 per Public Share or (ii) the lesser amount per Public Share held in the Trust Account as of the date of the liquidation
of the Trust Account due to reductions in the value of the trust assets, in each case net of taxes payable, provided that such liability
will not apply to any claims by a third party or Target that executed a waiver of any and all rights to seek access to the Trust Account
nor will it apply to any claims under the Company’s indemnity of the underwriter of the Initial Public Offering against certain
liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that
an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability
for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account
due to claims of creditors by endeavoring to have all vendors, service providers (other than the Company’s independent registered
public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with
the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.
Going Concern Consideration
As of September 30, 2024, the Company had $621,449
in cash and working capital deficit of approximately $6.8 million.
The Company’s liquidity needs prior to the
consummation of the Initial Public Offering were satisfied through the payment of $25,000 from the Sponsor to purchase Founder Shares,
and loan proceeds from the Sponsor of $300,000 under the Note (as defined in Note 4). The Company repaid the Note in full upon closing
of the Initial Public Offering. Subsequent to the consummation of the Initial Public Offering, the Company’s liquidity has been
satisfied through the net proceeds from the consummation of the Initial Public Offering and the Private Placement held outside of the
Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor, members
of the Company’s founding team or any of their affiliates may provide the Company with Working Capital Loans (as defined in Note
4) as may be required (of which up to $1.5 million may be converted at the lender’s option into warrants).
On October 30, 2023, the Sponsor loaned the Company
$380,000 and the Company issued an unsecured promissory note in the total principal amount of up to $380,000 to the Sponsor.
On March 1, 2024, the Company issued an unsecured
convertible promissory note in the total principal amount of up to $900,000 (the “First Sponsor Note”) to Sponsor. The First
Sponsor Note does not bear interest on the unpaid principal balance and matures upon closing of the Company’s initial business combination.
In the event that the Company does not consummate an initial business combination, the First Sponsor Note will be repaid solely to the
extent that the Company has funds available to it, if any, outside of its trust account established in connection with its initial public
offering of its securities. The proceeds of the First Sponsor Note will be used to fund ongoing operating expenses of the Company. The
total principal amount of the First Sponsor Note may be converted, in whole or in part, at the option of the Sponsor, (i) into warrants
of the Company at a price of $1.00 per warrant, with each warrant exercisable for one Class A ordinary share, par value $0.0001 per share,
of the Company (“Class A Ordinary Share”), or (ii) into Class A Ordinary Shares equal to the quotient obtained by dividing
(i) the amount of accrued and outstanding of the promissory note, by (ii) $10.00. The warrants will be identical to the private placement
warrants issued to the Sponsor at the time of the initial public offering of the Company.
SK GROWTH OPPORTUNITIES CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2024
On September 27, 2024, the Company issued an unsecured
convertible promissory note in the total principal amount of up to $440,000 (the “Second Sponsor Note,” and collectively with
the First Sponsor Note, the “Sponsor Note”) to Sponsor. The Second Sponsor Note does not bear interest on the unpaid principal
balance and matures upon closing of the Company’s initial business combination. In the event that the Company does not consummate
an initial business combination, the Second Sponsor Note will be repaid solely to the extent that the Company has funds available to it,
if any, outside of its trust account established in connection with its initial public offering of its securities. The proceeds of the
Second Sponsor Note will be used to fund ongoing operating expenses of the Company. The total principal amount of the Second Sponsor Note
may be converted, in whole or in part, at the option of the Sponsor, (i) into warrants of the Company at a price of $1.00 per warrant,
with each warrant exercisable for one Class A ordinary share, par value $0.0001 per share, of the Company (“Class A Ordinary Share”),
or (ii) into Class A Ordinary Shares equal to the quotient obtained by dividing (i) the amount of accrued and outstanding of the promissory
note, by (ii) $10.00. The warrants will be identical to the private placement warrants issued to the Sponsor at the time of the initial
public offering of the Company.
As of September 30, 2024 and December 31, 2024, the Company has $1,720,000
and $380,000 in borrowings under the Sponsor Note, respectively.
In connection with the Company’s assessment
of going concern considerations in accordance with FASB ASC Topic 205-40, “Presentation of Financial Statements—Going Concern,”
the Company has until March 31, 2025, to consummate a Business Combination. It is uncertain that the Company will be able to consummate
a Business Combination by this time, and if a Business Combination is not consummated by this date, then there will be a mandatory liquidation
and subsequent dissolution of the Company.
Management has determined that the liquidity condition
and mandatory liquidation, should a Business Combination not occur, and potential subsequent dissolution raises substantial doubt about
the Company’s ability to continue as a going concern for a period of time within one year after the date that the financial statements
are issued. Management plans to address this uncertainty through the initial Business Combination as discussed above. There is no assurance
that the Company’s plans to consummate the initial Business Combination will be successful or successful within the Combination
Period. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Risks and Uncertainties
United States and global markets are experiencing
volatility and disruption following the geopolitical instability resulting from the ongoing Russia-Ukraine conflict and the recent escalation
of the Israel-Hamas conflict. In response to the ongoing Russia-Ukraine conflict, the North Atlantic Treaty Organization (“NATO”)
deployed additional military forces to eastern Europe, and the United States, the United Kingdom, the European Union and other countries
have announced various sanctions and restrictive actions against Russia, Belarus and related individuals and entities, including the removal
of certain financial institutions from the Society for Worldwide Interbank Financial Telecommunication (SWIFT) payment system. Certain
countries, including the United States, have also provided and may continue to provide military aid or other assistance to Ukraine and
to Israel, increasing geopolitical tensions among a number of nations. The Russia-Ukraine conflict and the escalation of the Israel-Hamas
conflict and the resulting measures that have been taken, and could be taken in the future, by NATO, the United States, the United Kingdom,
the European Union, Israel and its neighboring states and other countries have created global security concerns that could have a lasting
impact on regional and global economies. Although the length and impact of the ongoing conflicts are highly unpredictable, they could
lead to market disruptions, including significant volatility in commodity prices, credit and capital markets, as well as supply chain
interruptions and increased cyberattacks against U.S. companies. Additionally, any resulting sanctions could adversely affect the global
economy and financial markets and lead to instability and lack of liquidity in capital markets.
Note 2—Summary of Significant Accounting
Policies
Basis of Presentation
The accompanying unaudited condensed financial
statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America
(“GAAP”) and Article 8 of Regulation S-X. Accordingly, certain disclosures included in the annual financial statements
have been condensed or omitted from these unaudited condensed financial statements as they are not required for interim financial statements
under GAAP and the rules of the SEC. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair
presentation have been included. Operating results for the three and nine months ended September 30, 2024 are not necessarily indicative
of the results that may be expected for the year ending December 31, 2024 or any future period.
The accompanying unaudited condensed financial
statements should be read in conjunction with the Company’s Form 10-K as filed with the SEC on March 29, 2024, which contains
the audited financial statements and notes thereto.
SK GROWTH OPPORTUNITIES CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2024
Emerging Growth Company
The Company is an “emerging growth company,”
as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS
Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies
that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public
accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding
executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory
vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act
exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies
(that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered
under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging
growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth
companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period,
which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company,
as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.
This may make comparison of the Company’s unaudited condensed financial statements with another public company that is neither an
emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible
because of the potential differences in accounting standards used.
Use of Estimates
The preparation of the unaudited condensed financial
statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial
statements and the reported amounts of expenses during the reporting periods. Actual results could differ from those estimates.
Making estimates requires management to exercise
significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances
that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near
term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Concentration of Credit Risk
Financial instruments that potentially subject
the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal
Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant
adverse impact on the Company’s financial condition, results of operations, and cash flows.
Cash and Cash Equivalents
The Company considers all short-term investments
with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents
as of September 30, 2024 and December 31, 2023.
Investments Held in the Trust Account
The Company’s portfolio of investments is
comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity
of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily
determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S.
government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account
are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market
funds are presented on the unaudited condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting
from the change in fair value of these securities are included in income from investments held in Trust Account in the accompanying unaudited
condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available
market information. As of September 30, 2024 and December 31, 2023, the assets held in the Trust Account were in money market funds.
SK GROWTH OPPORTUNITIES CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2024
Fair Value of Financial Instruments
The fair value of the Company’s assets and
liabilities, which qualify as financial instruments under FASB ASC Topic 820, “Fair Value Measurement,” approximates the carrying
amounts represented in the unaudited condensed balance sheets.
Fair Value Measurements
Fair value is defined as the price that would
be received for sale of an asset or paid for transfer of a liability in an orderly transaction between market participants at the measurement
date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy
gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and
the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:
| ● | Level 1,
defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; |
| ● | Level 2,
defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices
for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and |
| ● | Level 3,
defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions,
such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
In some circumstances, the inputs used to measure
fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is
categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Derivative Financial Instruments
The Company evaluates its financial instruments,
including equity-linked financial instruments, to determine if such instruments are derivatives or contain features that qualify as embedded
derivatives in accordance with FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). For freestanding derivative
financial instruments that are classified as liabilities, the derivative instrument is initially recognized at fair value with subsequent
changes in fair value recognized in the unaudited condensed statements of operations each reporting period. The classification of freestanding
derivative instruments, including whether such instruments should be classified as liabilities or as equity, is evaluated at the end of
each reporting period.
The Company evaluates embedded conversion features
within convertible debt instruments to determine whether the embedded conversion and other features should be bifurcated from the debt
host instrument and accounted for as a derivative in accordance with ASC 815.
The Company accounted for the warrants issued
in the Initial Public Offering and the Private Placement Warrants in accordance with the guidance contained in ASC 815. Application of
such guidance provides that the warrants are not precluded from equity classification. The warrants were initially measured at fair value.
Subsequent changes in fair value are not recognized as long as the contracts continue to be classified in equity.
The Partial Over-allotment option was recognized
as a derivative liability in accordance with ASC 815. Accordingly, the Company recognized the instrument as a liability at fair value
and adjusted the instrument to fair value at each reporting period. On August 9, 2022, following the expiration of the remaining
Over-Allotment Option, the Sponsor forfeited 510,000 Founder Shares and the derivative liability was extinguished.
The Non-Redemption Agreements were recognized as
a derivative instrument in accordance with ASC 815. The Non-Redemption Agreements represent a right to receive shares in the future contingent
upon the consummation of a business combination. Accordingly, any issuance of equity or the right to issue equity will be recorded as
an equity transaction and classified as additional paid-in capital and an expense to the company in connection to the non-redeemed shares.
The right to receive shares should be fair valued at inception and expensed in the period the agreement was entered into. As a result
of the equity classification conclusion will not be remeasured to fair valued at each reporting period.
Offering Costs Associated with the Initial
Public Offering
Offering costs consisted of legal, accounting,
underwriting and advisory fees and other costs incurred through the condensed balance sheet date that are directly related to the Initial
Public Offering. Upon completion of the Initial Public Offering, offering costs were allocated to the separable financial instruments
issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs allocated
to the warrants were charged to equity. Offering costs allocated to the Class A ordinary shares were charged against the carrying
value of Class A ordinary shares subject to possible redemption upon the completion of the Initial Public Offering.
SK GROWTH OPPORTUNITIES CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2024
Class A Ordinary Shares Subject to
Possible Redemption
The Company accounts for its Class A ordinary shares subject to possible
redemption in accordance with the guidance in ASC 480. Class A ordinary shares subject to mandatory redemption (if any) are classified
as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A
ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence
of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A
ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption
rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly,
as of September 30, 2024 and December 31, 2023, 9,732,960 and 10,056,597 Class A ordinary shares subject to possible redemption,
respectively, are presented as temporary equity, outside of the shareholders’ deficit section of the Company’s unaudited
condensed balance sheets.
The Company recognizes changes in redemption value
immediately as they occur and adjusts the carrying value of the Class A ordinary shares subject to possible redemption to equal the
redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption
date for the security. Effective with the closing of the Initial Public Offering, the Company recognized the accretion from initial book
value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit.
As of September 30, 2024 and December 31, 2023,
the amount of Class A ordinary shares subject to possible redemption reflected on the unaudited condensed balance sheets is reconciled
in the following table:
Class A ordinary shares subject to possible redemption, December 31, 2022 | |
| 217,545,818 | |
Plus: | |
| | |
Accretion of carrying value to redemption value | |
| 2,300,710 | |
Class A ordinary shares subject to possible redemption, March 31, 2023 | |
$ | 219,846,528 | |
Plus: | |
| | |
Accretion of carrying value to redemption value | |
| 2,457,660 | |
Class A ordinary shares subject to possible redemption, June 30, 2023 | |
$ | 222,304,188 | |
Plus: | |
| | |
Accretion of carrying value to redemption value | |
| 2,875,342 | |
Class A ordinary shares subject to possible redemption, September 30, 2023 | |
$ | 225,179,530 | |
Less: | |
| | |
Redemptions | |
| (118,642,864 | ) |
Plus: | |
| | |
Accretion of carrying value to redemption value | |
| 2,936,613 | |
Class A ordinary shares subject to possible redemption, December 31, 2023 | |
$ | 109,473,279 | |
Plus: | |
| | |
Accretion of carrying value to redemption value | |
| 1,427,435 | |
Class A ordinary shares subject to possible redemption, March 31, 2024 | |
$ | 110,900,714 | |
Plus: | |
| | |
Accretion of carrying value to redemption value | |
| 1,440,517 | |
Class A ordinary shares subject to possible redemption, June 30, 2024 | |
$ | 112,341,231 | |
Plus: | |
| | |
Accretion of carrying value to redemption value | |
| 1,457,119 | |
Less: | |
| | |
Redemptions | |
| (3,663,464 | ) |
Class A ordinary shares subject to possible redemption, September 30, 2024 | |
$ | 110,134,886 | |
SK GROWTH OPPORTUNITIES CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2024
Net Income per Ordinary Share
The Company complies with accounting and disclosure
requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as
Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares.
Net income per ordinary share is computed by dividing
net income by the weighted-average number of ordinary shares outstanding during the periods. Remeasurement associated with the redeemable
Class A ordinary shares is excluded from net income per ordinary share as the redemption value approximates fair value. Therefore,
the net income per ordinary share calculation allocates income shared pro rata between Class A and Class B ordinary shares.
The Company has not considered the effect of the exercise of the Public Warrants and Private Placement Warrants to purchase an aggregate
of 17,272,000 shares in the calculation of diluted income per ordinary share, since the exercise of the warrants is contingent
upon the occurrence of future events.
The following table reflects the calculation of
basic and diluted net income per ordinary share (in dollars, except per share amounts):
| |
For the Three Months Ended September 30, | |
| |
2024 | | |
2023 | |
| |
Class A | | |
Class B | | |
Class A | | |
Class B | |
Basic and diluted net income per ordinary share: | |
| | |
| | |
| | |
| |
Numerator: | |
| | |
| | |
| | |
| |
Allocation of net income | |
$ | 733,901 | | |
$ | 382,935 | | |
$ | 1,481,791 | | |
$ | 370,448 | |
Denominator: | |
| | | |
| | | |
| | | |
| | |
Weighted average ordinary shares outstanding—basic and diluted | |
| 10,042,526 | | |
| 5,240,000 | | |
| 20,960,000 | | |
| 5,240,000 | |
Net income per ordinary share—basic and diluted | |
$ | 0.07 | | |
$ | 0.07 | | |
$ | 0.07 | | |
$ | 0.07 | |
| |
For the Nine Months Ended September 30, | |
| |
2024 | | |
2023 | |
| |
Class A | | |
Class B | | |
Class A | | |
Class B | |
Basic and diluted net income per ordinary share: | |
| | |
| | |
| | |
| |
Numerator: | |
| | |
| | |
| | |
| |
Allocation of net income | |
$ | 1,444,814 | | |
$ | 753,175 | | |
$ | 4,849,114 | | |
$ | 1,212,278 | |
Denominator: | |
| | | |
| | | |
| | | |
| | |
Weighted average ordinary shares outstanding—basic and diluted | |
| 10,051,872 | | |
| 5,240,000 | | |
| 20,960,000 | | |
| 5,240,000 | |
Net income per ordinary share—basic and diluted | |
$ | 0.14 | | |
$ | 0.14 | | |
$ | 0.23 | | |
$ | 0.23 | |
Stock Compensation
The Company accounts for stock-based compensation
expense in accordance with FASB ASC Topic 718, “Compensation-Stock Compensation” (“ASC 718”). Under ASC 718,
stock-based compensation associated with equity awards is measured at fair value upon the grant date and recognized over the requisite
service period. To the extent a stock-based award is subject to a performance condition, the amount of expense recorded in a given period,
if any, reflects an assessment of the probability of achieving such performance condition, with compensation recognized once the event
is deemed probable to occur. Forfeitures are recognized as incurred.
Income Taxes
Income Taxes FASB ASC Topic 740, “Income
Taxes” prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of
tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than
not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of September 30, 2024 and December
31, 2023. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company
recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of September 30, 2024 and December
31, 2023, there were no unrecognized tax benefits and no amounts were accrued for the payment of interest and penalties.
The Company is currently not aware of any issues
under review that could result in significant payments, accruals or material deviation from its position. There is currently no taxation
imposed on income by the government of the Cayman Islands. In accordance with the Cayman Islands’ income tax regulations, income
taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s unaudited condensed financial
statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over
the next twelve months.
SK GROWTH OPPORTUNITIES CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2024
Recent Accounting Pronouncements
Management does not believe that any recently
issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited
condensed financial statements.
Note 3—Initial Public Offering
On June 28, 2022, the Company consummated
its Initial Public Offering of 20,000,000 Units, at $10.00 per Unit, generating gross proceeds of $200.0 million,
and incurring offering costs of approximately $12.0 million, of which $7.0 million was for deferred underwriting commissions.
The underwriter was granted the Over-Allotment
Option to purchase up to 3,000,000 additional Units to cover over-allotments, if any, at $10.00 per Unit. On July 20, 2022, pursuant
to the underwriter’s notice of the partial exercise of the Over-Allotment Option, the Company sold an additional 960,000 Units,
at $10.00 per Unit, generating aggregate additional gross proceeds of $9.6 million to the Company and incurring deferred underwriting
commissions of $336,000. The remaining Over-Allotment Option expired on August 7, 2022. On August 9, 2022, following the
expiration of the remaining Over-Allotment Option, the Sponsor forfeited 510,000 Founder Shares (as defined in Note 4).
Each Unit consists of one share of Class A
ordinary shares, and one-half of one redeemable warrant (each, a “Public Warrant”). Each Public
Warrant entitles the holder to purchase one share of Class A ordinary shares at a price of $11.50 per share, subject to
adjustment (see Note 6).
Note 4—Related Party Transactions
Founder Shares
On December 9, 2021, the sponsor purchased 8,625,000 Class B
ordinary shares, par value $0.0001 (the “Founder Shares”), to cover certain expenses on the Company’s behalf for
an aggregate purchase price of $25,000. On February 24, 2022, 1,437,500 Class B ordinary shares were surrendered and
thereupon cancelled by the Company. On May 5, 2022, 1,437,500 Class B ordinary shares were surrendered and thereupon
cancelled by the Company resulting in a decrease in the total number of Class B ordinary shares outstanding to 5,750,000 shares.
The Sponsor agreed to forfeit up to an aggregate of 750,000 Founder Shares to the extent that the option to purchase additional
Units is not exercised in full by the underwriter or is reduced, so that the Founder Shares would represent 20% of the Company’s
issued and outstanding shares upon the Initial Public Offering. On July 20, 2022, the Company sold an additional 960,000 Units
in the Partial Over-Allotment Exercise pursuant to the underwriter’s notice of the partial exercise of the Over-Allotment Option.
On August 9, 2022, following the expiration of the remaining Over-Allotment Option, the Sponsor forfeited 510,000 Founder
Shares.
The initial shareholders, and the executive officers
and directors of the Company, agreed not to transfer, assign or sell any of their Founder Shares until the earlier to occur of (i) one
year after the completion of the initial Business Combination; and (ii) subsequent to the initial Business Combination (x) the
date on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the shareholders
having the right to exchange their Class A ordinary shares for cash, securities or other property or (y) if the closing price
of Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations,
recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days
after the initial Business Combination. Any permitted transferees will be subject to the same restrictions and other agreements of the
initial shareholders with respect to any Founder Shares.
In February and March 2022, the Sponsor transferred
an aggregate of 90,000 Class B ordinary shares to the Company’s independent director nominees. The sale of the Founder
Shares is in the scope of ASC 718. The Founder Shares were granted subject to a performance condition (i.e., the occurrence of a
Business Combination). Compensation expense related to the Founder Shares is recognized only when the performance condition is probable
of occurrence under the applicable accounting literature in this circumstance. As of September 30, 2024, the Company determined that
a Business Combination is not considered probable, and, therefore, no stock-based compensation expense has been recognized. Stock-based
compensation will be recognized at the date a Business Combination is considered probable (i.e., upon consummation of a Business Combination)
in an amount equal to the number of Founder Shares that ultimately vest multiplied times the grant date fair value per share (unless
subsequently modified) less the amount initially received for the purchase of the Founder Shares.
SK GROWTH OPPORTUNITIES CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2024
Private Placement Warrants
Simultaneously with the closing of the Initial
Public Offering, the Company consummated the Private Placement of 6,600,000 Private Placement Warrants, at a price of $1.00 per
Private Placement Warrant, in a private placement to the Sponsor, generating proceeds of $6.6 million.
Substantially concurrently with the closing of
the Partial Over-Allotment Exercise, the Company completed the Additional Private Placement of 192,000 additional Private Placement
Warrants to the Sponsor at a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds to the Company
of $192,000.
A portion of the proceeds from the sale of the
Private Placement Warrants was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not
complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The purchasers of
the Private Placement Warrants agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants
(except to permitted transferees) until 30 days after the completion of the initial Business Combination.
Related Party Loans
Promissory Note to Sponsor
The Sponsor agreed to loan the Company up to $300,000 to
be used for the payment of costs related to the Initial Public Offering pursuant to a promissory note, dated on December 9, 2021
and was later amended on May 5, 2022 (the “Note”). The Note was non-interest bearing, unsecured and due upon the closing
of the Initial Public Offering. The Company borrowed $300,000 under the Note and repaid the Note in full upon closing of the Initial Public
Offering. The Note was no longer available to draw on after the consummation of the Initial Public Offering.
Overfunding Loans
On June 28, 2022, in connection with the
closing of the Initial Public Offering, the Sponsor loaned the Company $5.0 million under a non-interest bearing loan agreement
(the “First Overfunding Loan”) to deposit in the Trust Account. On July 20, 2022, in connection with the Partial Over-Allotment
Exercise, the Sponsor provided the Company with the second Overfunding Loan in the amount of $240,000 to deposit in the Trust
Account under the same terms (the “Second Overfunding Loan”, together, the “Overfunding Loans”). The Overfunding
Loans will be repaid upon the closing of an initial Business Combination or converted into Class A ordinary shares at a conversion
price of $10.00 per Class A ordinary share (or a combination of both), at the Sponsor’s discretion, provided that any
such conversion may not occur until August 22, 2022. If the Company does not complete an initial Business Combination, it will not
repay the Overfunding Loans from amounts held in the Trust Account, and the Trust Account proceeds will be distributed to the Public Shareholders;
however, the Company may repay the Overfunding Loans if there are funds available outside the Trust Account to do so. As of September
30, 2024 and December 31, 2023, the Company had $5,240,000 in borrowings under the First Overfunding Loan.
Working Capital Loans
In addition, in order to finance transaction costs
in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and
directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company
completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released
to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that
a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital
Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either
be repaid upon consummation of a Business Combination or, at the lender’s discretion, up to $1,500,000 of such Working Capital
Loans may be convertible into warrants of the post Business Combination entity at a price of $1.00 per warrant. The warrants would
be identical to the Private Placement Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been
determined and no written agreements exist with respect to such loans. As of September 30, 2024 and December 31, 2023, the Company had no borrowings
under the Working Capital Loans.
Promissory Notes
On October 30, 2023, the Sponsor loaned the Company
$380,000 and the Company issued an unsecured promissory note in the total principal amount of up to $380,000 to the Sponsor, which does
not bear interest on the unpaid principal balance and matures upon closing of the company’s initial business combination and shall
be convertible at the election of the sponsor into warrants exercisable for one Class A ordinary share of the post-business combination
company at a price of $1.00 per warrant.
SK GROWTH OPPORTUNITIES CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2024
On March 1, 2024, the Company issued an unsecured
convertible promissory note in the total principal amount of up to $900,000 (the “First Sponsor Note”) to Sponsor. The First
Sponsor Note does not bear interest on the unpaid principal balance and matures upon closing of the Company’s initial business combination.
In the event that the Company does not consummate an initial business combination, the First Sponsor Note will be repaid solely to the
extent that the Company has funds available to it, if any, outside of its trust account established in connection with its initial public
offering of its securities. The proceeds of the First Sponsor Note will be used to fund ongoing operating expenses of the Company. The
total principal amount of the First Sponsor Note may be converted, in whole or in part, at the option of the Sponsor, (i) into warrants
of the Company at a price of $1.00 per warrant, with each warrant exercisable for one Class A ordinary share, par value $0.0001 per share,
of the Company (“Class A Ordinary Share”), or (ii) into Class A Ordinary Shares equal to the quotient obtained by dividing
(i) the amount of accrued and outstanding of the promissory note, by (ii) $10.00. The warrants will be identical to the private placement
warrants issued to the Sponsor at the time of the initial public offering of the Company.
On September 27, 2024, the Company issued an unsecured
convertible promissory note in the total principal amount of up to $440,000 (the “Second Sponsor Note”) to Sponsor. The Second
Sponsor Note does not bear interest on the unpaid principal balance and matures upon closing of the Company’s initial business combination.
In the event that the Company does not consummate an initial business combination, the Second Sponsor Note will be repaid solely to the
extent that the Company has funds available to it, if any, outside of its trust account established in connection with its initial public
offering of its securities. The proceeds of the Second Sponsor Note will be used to fund ongoing operating expenses of the Company. The
total principal amount of the Second Sponsor Note may be converted, in whole or in part, at the option of the Sponsor, (i) into warrants
of the Company at a price of $1.00 per warrant, with each warrant exercisable for one Class A ordinary share, par value $0.0001 per share,
of the Company (“Class A Ordinary Share”), or (ii) into Class A Ordinary Shares equal to the quotient obtained by dividing
(i) the amount of accrued and outstanding of the promissory note, by (ii) $10.00. The warrants will be identical to the private placement
warrants issued to the Sponsor at the time of the initial public offering of the Company.
In the event that the Company does not consummate
an initial business combination, the promissory note will be repaid solely to the extent that the Company has funds available to it, if
any, outside of its trust account established in connection with its initial public offering of its securities. The proceeds of the promissory
note will be used to fund ongoing operating expenses of the Company.
As of September 30, 2024 and December 31, 2023,
the Company had $1,720,000 and $380,000, respectively, in borrowings under the Promissory Notes.
Extension Loans
In order to extend the time available for the
Company to consummate its initial Business Combination by an additional three months each time, the Sponsor or its affiliates or
designees may provide an Extension Loan to the Company to provide funds to deposit into the Trust Account an additional amount of $0.10 per
share each time. The Extension Loan will be provided under the form of a non-interest bearing, unsecured promissory
note.
Such Extension Loans may be converted into warrants
upon the consummation of the initial business combination, at a price of $1.00 per warrant at the option of the lender. The warrants
would be identical to the Private Placement Warrants. If the Company completes the initial Business Combination, and the lender decides
not to convert the Extension Loans into warrants, the Company would repay such loaned amounts out of the proceeds of the Trust Account
released to the Company. If the Company does not complete a Business Combination, it will not repay such loans. The Sponsor and its affiliates
or designees are not obligated to fund the Trust Account to extend the time for the Company to complete the initial Business Combination.
Except for the foregoing, the terms of such Extension Loans, if any, have not been determined and no written agreements exist with respect
to such loans. As of September 30, 2024 and December 31, 2023, the Company had $0 in borrowings under the Extension Loans.
Administrative Services Agreement
On June 23, 2022, the Company entered into
an agreement with an affiliate of the Sponsor, pursuant to which the Company agreed to pay such affiliate a total of $10,000 per
month for secretarial and administrative support services provided to the Company through the earlier of consummation of the initial Business
Combination and the Company’s liquidation. The Company incurred $30,000 and $90,000 in such fees included as general and
administrative expenses on the accompanying unaudited condensed statements of operations for the three and nine months ended September
30, 2024. As of September 30, 2024, the Company fully paid for such services. The Company incurred $30,000 and $90,000 in such fees
included as general and administrative expenses on the accompanying unaudited condensed statements of operations for the three and nine
months ended September 30, 2023. As of September 30, 2023, the Company fully paid for such services.
In addition, the Sponsor, officers and directors,
or any of their respective affiliates, will be reimbursed for any out-of-pocket expenses incurred in connection with activities on the
Company’s behalf such as identifying potential target businesses and performing due diligence on suitable Business Combinations.
The audit committee will review on a quarterly basis all payments that were made to the Sponsor, officers, directors or their affiliates
and will determine which expenses and the amount of expenses that will be reimbursed. There is no cap or ceiling on the reimbursement
of out-of-pocket expenses incurred by such persons in connection with activities on the Company’s behalf.
SK GROWTH OPPORTUNITIES CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2024
Note 5—Commitments and Contingencies
Shareholder and Registration Rights
Pursuant to a registration and shareholder rights
agreement entered into on June 23, 2022, the holders of Founder Shares, Private Placement Warrants, Class A ordinary shares
underlying the Private Placement Warrants and any warrants that may be issued upon conversion of Working Capital Loans and Extension Loans
(and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon
conversion of Working Capital Loans and Extension Loans), have registration rights to require the Company to register a sale of any of
the securities held by them. These holders are entitled to certain demand and “piggyback” registration rights. However, the
registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration
statement to become effective until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection
with the filing of any such registration statements.
Underwriting and Advisory Agreement
The underwriter was entitled to an underwriting
discount of $0.20 per Unit, or $4.0 million in the aggregate, paid upon the closing of the Initial Public Offering. An additional
fee of $0.35 per Unit, or approximately $7.0 million in the aggregate will be payable to the underwriter for deferred underwriting
commissions. The deferred fee will become payable to the underwriter from the amounts held in the Trust Account solely in the event that the
Company completes a Business Combination, subject to the terms of the underwriting agreement.
The Company also engaged Cohen & Company
Capital Markets (“CCM”) to provide consulting and advisory services to the Company in connection with the Initial Public Offering,
for which it would receive (i) an advisory fee of $400,000, paid upon the closing of the Initial Public Offering, and (ii) a
deferred advisory fee of $700,000 (payable solely in the event that the Company completes the initial Business Combination). The underwriter
has reimbursed a portion of its fees to cover for the fees payable to CCM.
In connection with the consummation of the Partial
Over-Allotment Exercise, the underwriter and CCM were entitled to an additional fee in the aggregate amount of $192,000, paid upfront
on July 20, 2022, and $336,000 in deferred underwriting and advisory commissions (net of the reimbursement from the
underwriter to cover for the fees payable to CCM).
On February 27, 2024, Deutsche Bank Securities
Inc., agreed to waive its entitlement to the payment of any underwriting discount due to it pursuant to the Underwiring Agreement in connection
with the Company’s potential business combination with Webull.
Non-Redemption Agreements
In connection with the First Extension Meeting to approve the First Extension
Amendment Proposal, the Company and Sponsor entered into non-redemption agreements (the “Non-Redemption Agreements”) with
several unaffiliated third parties (the “Investors”), pursuant to which such third parties agreed not to redeem (or to validly
rescind any redemption requests on) an aggregate of 8,530,242 Class A ordinary shares, par value $0.0001 per share (the “Class A
Ordinary Shares”) of the Company in connection with the First Extension Amendment Proposal. In exchange for the foregoing commitments
not to redeem such Class A Ordinary Shares of the Company, (i) the Sponsor agreed to surrender to the Company and forfeit for
no consideration an aggregate of 1,279,536 Class B ordinary shares, par value $0.0001 per share (the “Class B Ordinary
Shares” and together with the Class A Ordinary Shares, the “Ordinary Shares”) of the Company and (ii) the
Company agreed to issue or cause to be issued to the Investors for no additional consideration an aggregate of 1,279,536 Class A
Ordinary Shares of the Company, each in connection with the Company’s completion of its initial business combination. The Non-Redemption
Agreements increased the amount of funds that remain in the Company’s Trust Account following the First Extension Meeting.
The Company estimated the aggregate fair value
of the Class A Ordinary Shares attributable to the Investors to be $274,826 or $0.21 per share. Accordingly, in substance, it was
recognized by the Company as an expense to induce these holders of the Class A shares not to redeem, with a corresponding charge
to additional paid-in capital to recognize the fair value of the shares transferred as an offering cost.
The fair value of the Class A Ordinary Shares
was based on a Monte Carlo model using the following significant inputs:
| |
December 27, 2023 | |
Stock price | |
$ | 10.86 | |
Volatility | |
| 40.00 | % |
Term (years) | |
| 1.59 | |
Risk-free rate | |
| 4.44 | % |
SK GROWTH OPPORTUNITIES CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2024
Business Combination Agreement
On February 27, 2024, the Company (“SPAC”),
Webull Corporation, an exempted company limited by shares incorporated under the laws of the Cayman Islands (“Webull”), Feather
Sound I Inc., an exempted company limited by shares incorporated under the laws of the Cayman Islands and a direct wholly owned subsidiary
of Webull (“Merger Sub I”),and Feather Sound II Inc., an exempted company limited by shares incorporated under the laws of
the Cayman Islands and a direct wholly owned subsidiary of Webull (“Merger Sub II”, collectively with Merger Sub I, the “Merger
Subs” and each a “Merger Sub”),entered into a business combination agreement (the “Business Combination Agreement”).
Subject to, and in accordance with the terms and
conditions of the Business Combination Agreement, (i) immediately prior to the effective time of the First Merger (as defined below) (the
“First Merger Effective Time”), Webull will effectuate the Company Capital Restructuring (as defined in the Business Combination
Agreement), (ii) promptly following the Webull Capital Restructuring and at the First Merger Effective Time, Merger Sub I will merge with
and into us (the “First Merger”), with us surviving the First Merger as a wholly owned subsidiary of Webull (sometimes referred
to herein as the “Surviving Entity”), and (iii) promptly following the First Merger and at the effective time of the Second
Merger (as defined below) (the “Second Merger Effective Time”), the Surviving Entity will merge with and into Merger Sub II
(the “Second Merger”, together with the First Merger, the “Mergers”), with Merger Sub II surviving the Second
Merger as a wholly owned subsidiary of Webull. The Webull Capital Restructuring, the Mergers and each of the other transactions contemplated
by the Business Combination Agreement or other transaction documents are collectively referred to as the “Transactions” or
the “Business Combination”.
Concurrently with the execution and delivery of
the Business Combination Agreement, SPAC, Webull and Sponsor and certain directors (collectively, “SPAC Insiders”) have entered
into a support agreement (the “Sponsor Support Agreement”), pursuant to which, each SPAC Insider agreed, among other things,
(a) at any meeting of SPAC shareholders called to seek the SPAC Shareholders’ Approval or SPAC Shareholder Extension Approval
(as defined in the Business Combination Agreement), or in connection with any written consent of SPAC shareholders or in any other circumstances
upon which a vote, consent or other approval with respect to the Business Combination Agreement and the Transactions, such SPAC Insider
(i) agreed to, if a meeting is held, appear at such meeting or otherwise cause the SPAC Class B Ordinary Shares held by such
SPAC Insider to be counted as present at such meeting for purposes of establishing a quorum, and (ii) vote or cause to be voted the
SPAC Class B Ordinary Shares held by such SPAC Insider in favor of the SPAC Shareholders’ Approval or the SPAC Shareholder
Extension Approval; and (b) subject to the exceptions set forth in the Sponsor Support Agreement, agreed to become subject to certain
transfer restrictions with respect to (i) any Company Ordinary Shares held by each SPAC Insider immediately after the First Merger
Effective Time (as defined in the Business Combination Agreement) during a period of twelve (12) months from and after the Closing
Date (as defined in the Business Combination Agreement), (ii) Company Warrants or Class A Ordinary Shares underlying such warrants
held by each SPAC Insiders immediately after the First Merger Effective Time until thirty (30) days after the Closing Date.
Sponsor also agreed to forfeit for no consideration
up to 2,000,000 SPAC Class B Ordinary Shares held by Sponsor in connection with the execution of additional Non-Redemption Agreements
following the date of the Business Combination Agreement. In addition, on the terms and subject to the conditions of the Sponsor Support
Agreement, Webull agreed to indemnify Sponsor and each other SPAC Insider for any U.S. federal (and applicable U.S. state and U.S. local)
income taxes, together with any interests and penalties (the “Indemnifiable Amounts”) payable by Sponsor or the SPAC Insiders,
as applicable, solely arising from or attributable to the failure of the Mergers (as defined in the Business Combination Agreement) to
qualify as a reorganization within the meaning of Section 368(a) of the Internal Revenue Code of 1986, as amended (the “Code”)
or as an exchange described in Section 351 of the Code (the “Intended Tax Treatment”), provided, however, that the Company
shall not have any liability in respect of any Indemnifiable Amounts to the extent that the aggregate amount of such Indemnifiable Amounts
exceeds $5,000,000.
Note 6—Class A Ordinary Shares Subject
to Possible Redemption and Shareholders’ Deficit
Preference Shares—The Company
is authorized to issue 990,000 preference shares, par value $0.0001 per share. As of September 30, 2024 and December 31,
2023, there were no preference shares issued or outstanding.
Class A Ordinary Shares—The Company is authorized to issue 9,000,000,000 Class A
ordinary shares with a par value of $0.0001 per share. As of September 30, 2024 and December 31, 2023, there were 9,732,960 and 10,056,597,
respectively, Class A ordinary shares issued and outstanding, all of which were subject to possible redemption and were classified
outside of permanent equity deficit on the unaudited condensed balance sheets.
SK GROWTH OPPORTUNITIES CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2024
Class B Ordinary Shares—The
Company is authorized to issue 999,000,000 Class B ordinary shares with a par value of $0.0001 per share. As of December 31,
2022, there were 5,240,000 Class B ordinary shares issued and outstanding, which amounts have been retroactively restated to reflect
the share surrenders of Class B ordinary shares to the Company on February 24, 2022 and May 5, 2022 as discussed in Note
4. Of the 5,750,000 Class B ordinary shares outstanding, up to an aggregate of 750,000 shares was subject to forfeiture to the extent
that the option to purchase additional Units is not exercised in full by the underwriter or is reduced, so that the Founder Shares would
represent 20% of the Company’s issued and outstanding shares after the Initial Public Offering. On July 20, 2022, the Company
sold an additional 960,000 Units in the Partial Over-Allotment Exercise pursuant to the underwriter’s notice of the partial exercise
of the Over-Allotment Option. On August 9, 2022, following the expiration of the remaining Over-Allotment Option, the Sponsor forfeited
510,000 Founder Shares. As of September 30, 2024 and December 31, 2023 there were 5,240,000 Class B ordinary shares issued and outstanding.
Ordinary shareholders of record are entitled to one
vote for each share held on all matters to be voted on by shareholders. Except as described below, holders of the Class A ordinary
shares and holders of the Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the
Company’s shareholders, except as required by law.
The Class B ordinary shares will automatically
convert into Class A ordinary shares at the time of the initial Business Combination or earlier at the option of the holders thereof
at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate,
on an as-converted basis, 20% of the sum of (i) the total number of ordinary shares issued and outstanding
upon completion of the Initial Public Offering, plus (ii) (a) the total number of Class A ordinary shares issued or deemed issued
or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection
with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary shares or equity-linked
securities exercisable for or convertible into Class A ordinary shares issued, deemed issued, or to be issued to any seller in the
initial Business Combination and any private placement warrants issued to the Sponsor, its affiliates or any member of the management
team upon conversion of Working Capital Loans and Extension Loans and (b) any Class A ordinary shares issued to the Sponsor
upon conversion of Overfunding Loans. Any conversion of Class B ordinary shares described herein will take effect as a compulsory
redemption of Class B ordinary shares and an issuance of Class A ordinary shares as a matter of Cayman Islands law. In no event
will the Class B ordinary shares convert into Class A ordinary shares at a rate of less than one to one.
Warrants—As of September 30,
2024 and December 31, 2023, the Company had 10,480,000 Public Warrants and 6,792,000 Private Placement Warrants outstanding.
Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units
and only whole Public Warrants will trade. The Public Warrants will become exercisable 30 days after the completion of a Business
Combination, provided that the Company has an effective registration statement under the Securities Act covering the shares of ordinary
shares issuable upon exercise of the Public Warrants and a current prospectus relating to them is available (or the Company permits holders
to exercise their Public Warrants on a cashless basis and such cashless exercise is exempt from registration under the Securities Act).
The Company agreed that as soon as practicable, but in no event later than 15 business days after the closing of the Business
Combination, the Company will use its best efforts to file with the SEC a registration statement for the registration, under the Securities
Act, of the ordinary shares issuable upon exercise of the Public Warrants and the Private Placement Warrants. The Company will use its
best efforts to cause the same to become effective within 60 business days after the closing of the Business Combination and
to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the Public
Warrants and the Private Placement Warrants in accordance with the provisions of the warrant agreement. Notwithstanding the foregoing,
if the Company’s ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such
that it satisfies the definition of a “covered security” under the Securities Act, the Company, at its option, may require
holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9)
of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration
statement. The Public Warrants and Private Placement Warrants will expire five years after the completion of the Business Combination
or earlier upon the Company’s redemption or liquidation.
The warrants have an exercise price of $11.50 per
share, subject to adjustments, and will expire five years after the completion of a Business Combination or earlier upon redemption
or liquidation. In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital
raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less
than $9.20 per ordinary share (with such issue price or effective issue price to be determined in good faith by the board of directors
and, in the case of any such issuance to the initial shareholders or their affiliates, without taking into account any Founder Shares
held by such shareholder) (the “Newly Issued Price”), (y) the proceeds from such issuances represent more than 60% of
the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation
of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Class A ordinary
shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates the initial
Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will
be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per
share redemption trigger price described under “Redemption of Public Warrants” will be adjusted (to the nearest cent) to be
equal to 180% of the higher of the Market Value and the Newly Issued Price.
SK GROWTH OPPORTUNITIES CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2024
The Private Placement Warrants are identical to
the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants (i) will
not be redeemable by the Company, (ii) may not, subject to certain limited exceptions, be transferred, assigned or sold by the holders
(and the Class A ordinary shares issuable upon exercise of these warrants may not be transferred, assigned or sold by the holders)
until 30 days after the completion of the initial Business Combination, (iii) may be exercised by the holders on a cashless
basis and (iv) will be entitled to registration rights.
Redemption of Public Warrants: Once
the Public Warrants become exercisable, the Company may redeem the outstanding Public Warrants:
| ● | in whole and not in part; |
| | |
| ● | at a price of $0.01 per warrant; |
| | |
| ● | upon a minimum of 30 days’ prior written notice of redemption, the “30-day redemption period”; and |
| | |
| ● | if, and only if, the last reported sale price (the “closing price”) of Class A ordinary shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the Public Warrant. |
The Company will not redeem the Public Warrants
as described above unless an effective registration statement under the Securities Act covering the Class A ordinary shares issuable
upon exercise of the warrants is effective and a current prospectus relating to those Class A ordinary shares is available throughout the 30-day redemption period
or the Company has elected to require the exercise of the Public Warrants on a “cashless basis”. If the Company calls the
Public Warrants for redemption as described above, the Company will have the option to require all holders that wish to exercise such
warrants to do so on a “cashless basis.”
Note 7—Fair Value Measurements
The following tables present information about
the Company’s financial assets that are measured at fair value on a recurring basis as September 30, 2024 and December 31, 2023
by level within the fair value hierarchy:
September 30, 2024 | |
Quoted Prices in Active Markets (Level 1) | | |
Significant Other Observable Inputs (Level 2) | | |
Significant Other Unobservable Inputs (Level 3) | |
Assets: | |
| | |
| | |
| |
Investments held in Trust Account – Money Market Funds | |
$ | 113,898,350 | | |
$ | — | | |
$ | — | |
December 31, 2023 | |
Quoted Prices in Active Markets (Level 1) | | |
Significant Other Observable Inputs (Level 2) | | |
Significant Other Unobservable Inputs (Level 3) | |
Assets: | |
| | |
| | |
| |
Investments held in Trust Account – Money Market Funds | |
$ | 109,573,279 | | |
$ | — | | |
$ | — | |
Transfers to/from Levels 1, 2, and 3 are recognized
at the beginning of the reporting period. There were no transfers between levels during the periods ended September 30, 2024 and December
31, 2023.
Note 8—Subsequent Events
The Company evaluated subsequent events and transactions
that occurred after the condensed balance sheet date up to the date that the unaudited condensed financial statements were issued. Based
upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited
condensed financial statements.
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS
OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
References in this report
(the “Quarterly Report”) to “we,” “us” or the “Company” refer to SK Growth Opportunities
Corporation References to our “management” or our “management team” refer to our officers and directors, and references
to the “Sponsor” refer to Auxo Capital Managers LLC. The following discussion and analysis of the Company’s financial
condition and results of operations should be read in conjunction with the unaudited condensed financial statements and the notes thereto
contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking
statements that involve risks and uncertainties.
Special Note Regarding Forward-Looking Statements
This Quarterly Report includes
“forward-looking statements” that are not historical facts and involve risks and uncertainties that could cause actual results
to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Quarterly
Report including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and
Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management
for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,”
“intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify
such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s
current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ
materially from the events, performance and results discussed in the forward-looking statements. For information identifying important
factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to
the Risk Factors section of the Company’s Annual Report on Form 10-K filed with the SEC on March 29, 2024. The Company’s securities
filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities
law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information,
future events or otherwise.
Overview
We are a blank check company
incorporated in the Cayman Islands on December 8, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange,
asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. We are an emerging growth
company and, as such, we are subject to all of the risks associated with emerging growth companies.
Our Sponsor is Auxo Capital
Managers LLC, a Delaware limited liability company. The registration statement for our Initial Public Offering was declared effective
on June 23, 2022. On June 28, 2022, we consummated our Initial Public Offering of 20,000,000 Units, at $10.00 per Unit, generating gross
proceeds of $200.0 million, and incurring offering costs of approximately $12.0 million, of which $7.0 million was for deferred underwriting
commissions. The underwriter was granted a 45-day option from the date of the final prospectus relating to the Initial Public Offering
to purchase up to 3,000,000 additional Units to cover over-allotments, if any, at $10.00 per Unit. On July 20, 2022, pursuant to the underwriter’s
notice of the partial exercise of the Over-Allotment Option, we sold an additional 960,000 Units, at $10.00 per Unit, generating aggregate
additional gross proceeds of $9.6 million to us. On August 7, 2022, the remaining Over-Allotment Option expired unexercised.
On August 10, 2022, the Company
announced that, effective August 15, 2022, the Company’s Class A ordinary shares and warrants comprising each issued and outstanding
Unit will commence trading separately under the ticker symbols “SKGR” and “SKGW,” respectively. Holders of Units
may elect to continue to hold Units or separate their Units into the component securities.
Simultaneously with the closing
of the Initial Public Offering, we consummated the Private Placement of 6,600,000 Private Placement Warrants, at a price of $1.00 per
Private Placement Warrant in a private placement to our Sponsor, generating proceeds of $6.6 million. Substantially concurrently with
the closing of the Partial Over-Allotment Exercise, we completed an additional private placement of 192,000 Private Placement Warrants
to our Sponsor at a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds to the Company of $192,000.
In addition, upon the consummation
of the Initial Public Offering on June 28, 2022, our Sponsor provided us with the First Overfunding Loan in the amount of $5.0 million
to deposit in the Trust Account at no interest. In connection with the Partial Over-Allotment Exercise on July 20, 2022, our Sponsor provided
us with the Second Overfunding Loan in the amount of $240,000 to deposit in the Trust Account.
Upon the closing of the Initial Public Offering and the Partial Over-Allotment
Exercise, approximately $214.8 million ($10.25 per Unit) of net proceeds, including the net proceeds of the Initial Public Offering, the
Partial Over-Allotment Exercise, the proceeds of the Overfunding Loans and certain of the proceeds of the Private Placement and the Additional
Private Placement, was placed in the Trust Account located in the United States with Continental Stock Transfer & Trust Company acting
as trustee, and invested only in United States “government securities” within the meaning of Section 2(a)(16) of the Investment
Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule2a-7 promulgated under
the Investment Company Act which invest only in direct U.S. government treasury obligations, as determined by us, until the earlier of:
(i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.
We will provide the Public
Shareholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either
(i) in connection with a shareholders meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision
as to whether we will seek shareholder approval of a Business Combination or conduct a tender offer will be made by us, solely in its
discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then held in the
Trust Account (initially at $10.25 per Public Share). The per-share amount to be distributed to Public Shareholders who redeem their Public
Shares will not be reduced by the deferred underwriting commissions we will pay to the underwriter.
If we are unable to consummate
an initial business combination prior to March 31, 2025 (such period, the “Combination Period”), we will (i) cease all operations
except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the
public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest
earned on the funds held in the trust account (less taxes payable and up to $100,000 of interest to pay dissolution expenses) divided
by the number of the then-outstanding public shares, which redemption will completely extinguish public shareholders’ rights as
shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible
following such redemption, subject to the approval of the remaining shareholders and the board of directors, liquidate and dissolve, subject
in each case to our obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.
Proposed Business Combination
On February 27, 2024, we
entered into a Business Combination Agreement (as may be amended, supplemented or otherwise modified from time to time, the “Business
Combination Agreement”) with Webull Corporation, an exempted company limited by shares incorporated under the laws of the Cayman
Islands (“Webull”), Feather Sound I Inc., an exempted company limited by shares incorporated under the laws of the Cayman
Islands and a direct wholly owned subsidiary of Webull (“Merger Sub I”) and Feather Sound II Inc., an exempted company limited
by shares incorporated under the laws of the Cayman Islands and a direct wholly owned subsidiary of Webull (“Merger Sub II”).
Termination
The Business Combination
Agreement may be terminated under certain customary and limited circumstances prior to the First Merger Effective Time, including, among
others: (i) by mutual written consent of Webull and us; (ii) by Webull or us if any law or governmental order is in effect that has become
final and non-appealable and has the effect of making the consummation of the Transactions illegal or otherwise preventing or prohibiting
consummation of the Transactions; (ii) by Webull if our board or any of its committees shall have withheld, withdrawn, qualified, amended
or modified, or publicly proposed to do any of the foregoing, with respect to our board recommendation that our shareholders vote in favor
of the SPAC Transaction Proposals (as defined in the Business Combination Agreement) at the duly convened meeting of our shareholders,
(iii) by Webull if we shall have failed to obtain the approval of our shareholders in an extraordinary general meeting in connection with
the amendment to our organizational documents to extend the deadline for us to consummate an initial business combination; (iv) by Webull
or us if the SPAC Shareholders’ Approval shall not have been obtained at the meeting of our shareholders, (v) by Webull or us if
the required approval by the shareholders of the Webull shall not have been obtained; (vi) by Webull or us upon a breach of or failure
to perform any representations, warranties, covenants or other agreements set forth in the Business Combination Agreement by the other
party if such breach gives rise to a failure of certain closing conditions to be satisfied and cannot or has not been cured; and (vii)
by Webull or us if the Transactions shall not have been consummated on or prior to the March 31, 2025, in each case subject to specified
exceptions.
The Business Combination
Agreement and related agreements are further described in our Current Report on Form 8-K filed with the SEC on February 28, 2024. Other
than as specifically discussed, this Quarterly Report does not assume the closing of the Business Combination or the transactions contemplated
by the Business Combination Agreement.
Sponsor Support Agreement
Concurrently with the execution
and delivery of the Business Combination Agreement, we have entered into a support agreement with Webull and the SPAC Insiders (the “Sponsor
Support Agreement”), pursuant to which, each SPAC Insider agreed, among other things, (a) at any meeting of our shareholders called
to seek SPAC Shareholders’ Approval or SPAC Shareholder Extension Approval (as defined in the Business Combination Agreement), or
in connection with any written consent of our shareholders or in any other circumstances upon which a vote, consent or other approval
with respect to the Business Combination Agreement and the Transactions, such SPAC Insider (i) agreed to, if a meeting is held, appear
at such meeting or otherwise cause our Class B ordinary shares held by such SPAC Insider to be counted as present at such meeting for
purposes of establishing a quorum, and (ii) vote or cause to be voted our Class B ordinary shares held by such SPAC Insider in favor of
the SPAC Shareholders’ Approval or the SPAC Shareholder Extension Approval; and (b) subject to the exceptions set forth in the Sponsor
Support Agreement, agreed to become subject to certain transfer restrictions with respect to (i) any Webull Ordinary Shares held by each
SPAC Insider immediately after the First Merger Effective Time during a period of twelve (12)-months from and after the Closing Date,
(ii) Webull Class A ordinary share (the “Webull Warrants”) or class A ordinary shares of Webull, par value $0.00001 per share
(the “Webull Class A Ordinary Shares”) underlying such warrants held by each SPAC Insiders immediately after the First Merger
Effective Time until thirty (30) days after the Closing Date.
Following the date of the
Business Combination Agreement, we and our sponsor will use commercially reasonable efforts to enter into additional Non-Redemption Agreements
with our public shareholders, pursuant to which our sponsor will be required to forfeit for no consideration 2,000,000 of Class B ordinary
shares held by our sponsor. To the extent the aggregate amount of our Class B ordinary shares to be forfeited by our sponsor pursuant
to such additional Non-Redemption Agreements is less than 2,000,000, our sponsor will forfeit an additional amount of our Class B ordinary
shares on the Closing Date and immediately prior to the First Merger Effective Time, such that our sponsor will forfeit an aggregate of
2,000,000 Class B ordinary shares pursuant to such additional Non-Redemption Agreements and the Sponsor Support Agreement.
In addition, on the terms
and subject to the conditions of the Sponsor Support Agreement, following the closing of the Business Combination until 30 days following
the expiration of the statute of limitations for the applicable taxes (or if an audit is commenced during this period, until the completion
of the audit), subject to the occurrence of certain triggering events, Webull agreed to indemnify our sponsor and each other SPAC Insiders
for any U.S. federal (and applicable U.S. state and U.S. local) income taxes, together with any interests and penalties (the “Indemnifiable
Amounts”) payable by our sponsor or the other SPAC Insiders, as applicable, solely arising from or attributable to the failure of
the Mergers to qualify as a reorganization within the meaning of Section 368(a) of the Internal Revenue Code of 1986, as amended (the
“Code”) or as an exchange described in Section 351 of the Code, provided, however, that Webull shall not have any liability
in respect of any Indemnifiable Amounts to the extent that the aggregate amount of such Indemnifiable Amounts exceeds $5,000,000.
The foregoing description
of the Sponsor Support Agreement does not purport to be complete and is qualified in its entirety by the terms and conditions of the Sponsor
Support Agreement, a copy of which is filed with our Current Report on Form 8-K filed with the SEC on February 28, 2024 which is incorporated
by reference herein.
Going Concern Consideration
As of September 30, 2024,
the company had $621,449 in cash and working capital deficit of approximately $6.8 million.
Our liquidity needs prior
to the consummation of the initial public offering were satisfied through the payment of $25,000 from our sponsor to purchase founder
shares, and loan proceeds from our sponsor of $300,000 under a promissory note, dated December 9, 2021 that was later amended on May 5,
2022 (the “Note”). We repaid the Note in full upon closing of the initial public offering. Subsequent to the consummation
of the initial public offering, our liquidity has been satisfied through the net proceeds from the consummation of the initial public
offering, the overfunding loans and the private placement held outside of the trust account. In addition, in order to finance transaction
costs in connection with a business combination, our sponsor, members of our founding team or any of their affiliates may provide us with
working capital loans as may be required (of which up to $1.5 million may be converted at the lender’s option into warrants).We
have incurred and expect to continue to incur significant costs in pursuit of our acquisition plans. In connection with our assessment
of going concern considerations in accordance with FASB ASC Topic 205-40, “Presentation of Financial Statements-Going Concern,”
we have until September 30, 2024 (or March 31, 2025 as may be approved as described in our Annual Report on Form 10-K filed with the SEC
on March 29, 2024) to consummate a business combination. It is uncertain that we will be able to consummate a business combination by
this time, and if a business combination is not consummated by this date, then there will be a mandatory liquidation and subsequent dissolution
of our company.
Our management has determined
that the liquidity condition and mandatory liquidation, should a business combination not occur, and potential subsequent dissolution
raises substantial doubt about our ability to continue as a going concern for a period of time within one year after the date that the
financial statements are issued. Our management plans to address this uncertainty through the initial business combination as discussed
above. There is no assurance that our plans to consummate the initial business combination will be successful or successful by March 31,
2025 as described in our Definitive Proxy Statement filed with the SEC on September 3, 2024, as amended by the Amendment to the Definitive
Proxy Statement filed with the SEC on September 17, 2024 and September 25, 2024, respectively. The financial statements do not include
any adjustments that might result from the outcome of this uncertainty.
Risks and Uncertainties
United States and global
markets are experiencing volatility and disruption following the geopolitical instability resulting from the ongoing Russia-Ukraine conflict
and the recent escalation of the Israel-Hamas conflict. In response to the ongoing Russia-Ukraine conflict, the North Atlantic Treaty
Organization (“NATO”) deployed additional military forces to eastern Europe, and the United States, the United Kingdom, the
European Union and other countries have announced various sanctions and restrictive actions against Russia, Belarus and related individuals
and entities, including the removal of certain financial institutions from the Society for Worldwide Interbank Financial Telecommunication
(SWIFT) payment system. Certain countries, including the United States, have also provided and may continue to provide military aid or
other assistance to Ukraine and to Israel, increasing geopolitical tensions among a number of nations. The Russia-Ukraine conflict and
the escalation of the Israel-Hamas conflict and the resulting measures that have been taken, and could be taken in the future, by NATO,
the United States, the United Kingdom, the European Union, Israel and its neighboring states and other countries have created global security
concerns that could have a lasting impact on regional and global economies. Although the length and impact of the ongoing conflicts are
highly unpredictable, they could lead to market disruptions, including significant volatility in commodity prices, credit and capital
markets, as well as supply chain interruptions and increased cyber-attacks against U.S. companies. Additionally, any resulting sanctions
could adversely affect the global economy and financial markets and lead to instability and lack of liquidity in capital markets.
Any of the above mentioned
factors, or any other negative impact on the global economy, capital markets or other geopolitical conditions resulting from the Russia-Ukraine
conflict, the escalation of the Israel-Hamas conflict and subsequent sanctions or related actions, could adversely affect the Company’s
search for an initial business combination and any target business with which the Company may ultimately consummate an initial business
combination.
Results of Operations
Our entire activity since
inception up to September 30, 2024, related to our formation, the preparation for the Initial Public Offering, and since the closing of
the Initial Public Offering, the search for a prospective initial Business Combination. We will not be generating any operating revenues
until the closing and completion of our initial Business Combination.
For the three months ended
September 30, 2024, we had a net income of approximately $1.1 million, which consisted of approximately $1.5 million in income from investments
held in the trust account, offset by approximately $340,000 in general and administrative expenses (of which $30,000 was for administrative
expenses for related party).
For the nine months ended
September 30, 2024, we had a net income of approximately $2.2 million, which consisted of approximately $4.3 million in income from investments
held in the trust account, offset by approximately $2.1 million in general and administrative expenses (of which $90,000 was for administrative
expenses for related party).
For the three months ended
September 30, 2023, we had a net income of approximately $1.9 million which consisted of approximately $2.9 million in
income from investments held in the Trust Account, offset by approximately $1.0 million in general and administrative expenses (of
which $30,000 was for administrative expenses for related party).
For the nine months ended September 30,
2023, we had a net income of approximately $6.1 million, which consisted of approximately $7.6 million in income from investments
held in the Trust Account, offset by approximately $1.6 million in general and administrative expenses (of which $90,000 was for
administrative expenses for related party).
Contractual Obligations
Shareholder and Registration Rights
Pursuant to a registration
and shareholder rights agreement entered into on June 23, 2022, the holders of Founder Shares, Private Placement Warrants, Class A ordinary
shares underlying the Private Placement Warrants and any warrants that may be issued upon conversion of Working Capital Loans and Extension
Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon
conversion of Working Capital Loans and Extension Loans), have registration rights to require us to register a sale of any of the securities
held by them. These holders are entitled to certain demand and “piggy-back” registration rights. However, the registration
rights agreement provides that we will not be required to effect or permit any registration or cause any registration statement to become
effective until termination of the applicable lock-up period. We will bear the expenses incurred in connection with the filing of any
such registration statements.
Underwriting and Advisory Agreement
The underwriter was entitled
to an underwriting discount of $0.20 per Unit, or $4.0 million in the aggregate, paid upon the closing of the Initial Public Offering.
An additional fee of $0.35 per Unit, or approximately $7.0 million in the aggregate will be payable to the underwriter for deferred underwriting
commissions. The deferred fee will become payable to the underwriter from the amounts held in the Trust Account solely in the event that
we complete a Business Combination, subject to the terms of the underwriting agreement.
We also engaged Cohen &
Company Capital Markets (“CCM”) to provide consulting and advisory services to us in connection with the Initial Public Offering,
for which it would receive: (i) an advisory fee of $400,000, paid upon the closing of the Initial Public Offering, and (ii) a deferred
advisory fee of $700,000 (payable solely in the event that we complete the initial Business Combination. The underwriter has reimbursed
a portion of their fees to cover for the fees payable to CCM.
In connection with the consummation
of the Partial Over-Allotment Exercise, the underwriter and CCM were entitled to an additional fee of $192,000, paid upfront on July 20,
2022, and $240,000 in deferred underwriting and advisory commissions, (net of the reimbursement from the underwriter to cover for the
fees payable to CCM).
Administrative Services Agreement
On June 23, 2022, we entered
into an agreement with an affiliate of our sponsor, pursuant to which we agreed to pay such affiliate a total of $10,000 per month for
secretarial and administrative support services provided to us through the earlier of consummation of the initial business combination
and our liquidation. We incurred $30,000 and $90,000 in such fees included as general and administrative expenses on the accompanying
unaudited condensed statements of operations for the three and nine months ended September 30, 2024. As of September 30, 2024, we fully
paid for such services. We incurred $30,000 and $90,000 in such fees included as general and administrative expenses on the accompanying
unaudited condensed statements of operations for the three and nine months ended September 30, 2023. As of September 30, 2023, we fully
paid for such services.
In addition, our sponsor,
officers and directors, or any of their respective affiliates, will be reimbursed for any out-of-pocket expenses incurred in connection
with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable business combinations.
The audit committee will review on a quarterly basis all payments that were made to our sponsor, officers, directors or their affiliates
and will determine which expenses and the amount of expenses that will be reimbursed. There is no cap or ceiling on the reimbursement
of out-of-pocket expenses incurred by such persons in connection with activities on our behalf.
Critical Accounting Estimates
The preparation of the unaudited
condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States
of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities,
disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements, and the reported amounts
of income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the
following as critical accounting estimates.
Derivative Financial Instruments
We evaluate our financial
instruments, including equity-linked financial instruments to determine if such instruments are derivatives or contain features that qualify
as embedded derivatives in accordance with FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). For freestanding
derivative financial instruments that are classified as liabilities, the derivative instrument is initially recognized at fair value with
subsequent changes in fair value recognized in the unaudited condensed statements of operations each reporting period. The classification
of freestanding derivative instruments, including whether such instruments should be classified as liabilities or as equity, is evaluated
at the end of each reporting period.
We evaluate embedded conversion
features within convertible debt instruments to determine whether the embedded conversion and other features should be bifurcated from
the debt host instrument and accounted for as a derivative in accordance with ASC 815.
We accounted for Public Warrants
and the Private Placement Warrants in accordance with the guidance contained in ASC 815. Application of such guidance provides that the
warrants are not precluded from equity classification. The warrants were initially measured at fair value. Subsequent changes in fair
value are not recognized as long as the contracts continue to be classified in equity.
The Over-Allotment Option
was recognized as a derivative liability in accordance with ASC 815. Accordingly, we recognized the instrument as a liability at fair
value and adjusted the instrument to fair value at each reporting period. On August 9, 2022, following the expiration of the remaining
Over-Allotment Option, the Sponsor forfeited 510,000 Founder Shares and the derivative liability was extinguished.
Class A Ordinary Shares Subject to Possible
Redemption
We account for our Class
A ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Class A ordinary shares subject to mandatory
redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary
shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to
redemption upon the occurrence of uncertain events not solely within our control) are classified as temporary equity. At all other times,
Class A ordinary shares are classified as shareholders’ equity. Our Class A ordinary shares feature certain redemption rights that
are considered to be outside of our control and subject to the occurrence of uncertain future events. Accordingly, as of September 30,
2024, 9,732,960 Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’
deficit section of our unaudited condensed balance sheets.
We recognize changes in redemption
value immediately as they occur and adjust the carrying value of the Class A ordinary shares subject to possible redemption to equal the
redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption
date for the security. Effective with the closing of the Initial Public Offering, we recognized the accretion from initial book value
to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit.
Recent Accounting Pronouncements
Our management do not believe
that any recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the
accompanying unaudited condensed financial statements.
Off-Balance Sheet Arrangements and Contractual
Obligations
As of September 30, 2024,
we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K and did not have any commitments
or contractual obligations.
JOBS Act
On April 5, 2012, the JOBS
Act was signed into law. The JOBS Act contains provisions that, among other things, relax certain reporting requirements for qualifying
public companies. We qualify as an “emerging growth company” under the JOBS Act and are allowed to comply with new or revised
accounting pronouncements based on the effective date for private (not publicly traded) companies. We elected to delay the adoption of
new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates
on which adoption of such standards is required for non-emerging growth companies. As a result, our unaudited condensed financial statements
may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.
As an “emerging growth
company”, we are not required to, among other things, (i) provide an auditor’s attestation report on our system of internal
controls over financial reporting pursuant to Section 404, (ii) provide all of the compensation disclosure that may be required of non-emerging
growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may
be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information
about the audit and the financial statements (auditor discussion and analysis), and (iv) disclose certain executive compensation related
items such as the correlation between executive compensation and performance and comparisons of the CEO’s compensation to median
employee compensation. These exemptions will apply for a period of five years following the completion of our initial public offering
or until we are no longer an “emerging growth company,” whichever is earlier.
Item 3. Quantitative and Qualitative Disclosures
About Market Risk
We are a smaller reporting
company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Disclosure controls and procedures
are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized,
and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated
to our management, including our principal executive officer and principal financial and accounting officer or persons performing similar
functions, as appropriate to allow timely decisions regarding required disclosure.
Under the supervision and
with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation
of the effectiveness of our disclosure controls and procedures as of September 30, 2024, as such term is defined in Rules 13a-15(e) and
15d-15(e) under the Exchange Act. Based on this evaluation, our principal executive officer and principal financial officer have concluded
that during the period covered by this report, our disclosure controls and procedures were effective as of September 30, 2024.
Changes in Internal Control Over Financial
Reporting
During the most recently
completed fiscal quarter, there has been no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and
15d-15(f) under the Exchange Act) that has materially affected, or is reasonably likely to materially affect, our internal control over
financial reporting.
PART II-OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
None.
ITEM 1A. RISK FACTORS
As of the date of this Quarterly
Report on Form 10-Q, there have been no material changes to the risk factors disclosed in our Definitive Proxy Statement filed with the
SEC on September 3, 2024, as amended by that certain Amendment to the Definitive Proxy Statement filed with the SEC on September 17, 2024
and September 25, 2024, respectively. We may disclose changes to such factors or disclose additional factors from time to time in our
future filings with the SEC.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES
AND USE OF PROCEEDS
Unregistered Sales of Equity Securities
We have not sold any equity
securities during the quarter ended September 30, 2024.
Use of Proceeds
In connection with the Initial
Public Offering and the Partial Over-Allotment Exercise, we incurred offering costs of approximately $12.6 million (including deferred
underwriting commissions of approximately $7.3 million). Other incurred offering costs consisted principally of preparation fees related
to the Initial Public Offering. After deducting the underwriting discounts and commissions (excluding the deferred portion, which amount
will be payable upon consummation of the initial Business Combination, if consummated) and the Initial Public Offering expenses, approximately
$214.8 million of the net proceeds of the Initial Public Offering, the Partial Over-Allotment Exercise, the proceeds of the Overfunding
Loans and certain of the proceeds of the Private Placement and the Additional Private Placement was placed in the Trust Account. The net
proceeds of the Initial Public Offering, the Partial Over-Allotment Exercise, the proceeds of the Overfunding Loans and certain of the
proceeds of the Private Placement and the Additional Private Placement are held in the Trust Account and invested as described elsewhere
in this Quarterly Report on Form 10-Q.
There has been no material
change in the planned use of the proceeds from the Initial Public Offering, the Overfunding Loan and the Private Placement as is described
in the Company’s final prospectus related to the Initial Public Offering.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
None.
ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
ITEM 5. OTHER INFORMATION
No officers or directors,
as defined in Rule 16a-1(f), adopted and/or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading
arrangement,” as defined in Regulation S-K Item 408, during the last fiscal quarter.
ITEM 6. EXHIBITS
The following exhibits are
filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.
* |
Filed herewith |
** |
These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing. |
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
|
SK GROWTH OPPORTUNITIES CORPORATION |
|
|
|
|
Date: November 13, 2024 |
By: |
/s/ Richard Chin |
|
|
Name: |
Richard Chin |
|
|
Title: |
Chief Executive Officer |
Date: November 13, 2024 |
By: |
/s/ Derek Jensen |
|
|
Name: |
Derek Jensen |
|
|
Title: |
Chief Financial Officer |
29
0.5
false
--12-31
Q3
0001912461
0001912461
2024-01-01
2024-09-30
0001912461
skgr:UnitsEachConsistingOfOneClassAOrdinaryShare00001ParValueAndOnehalfOfOneRedeemableWarrantMember
2024-01-01
2024-09-30
0001912461
us-gaap:CommonClassAMember
2024-01-01
2024-09-30
0001912461
skgr:RedeemableWarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150Member
2024-01-01
2024-09-30
0001912461
us-gaap:CommonClassAMember
2024-11-13
0001912461
us-gaap:CommonClassBMember
2024-11-13
0001912461
2024-09-30
0001912461
2023-12-31
0001912461
us-gaap:CommonClassAMember
2024-09-30
0001912461
us-gaap:CommonClassAMember
2023-12-31
0001912461
us-gaap:CommonClassBMember
2024-09-30
0001912461
us-gaap:CommonClassBMember
2023-12-31
0001912461
2024-07-01
2024-09-30
0001912461
2023-07-01
2023-09-30
0001912461
2023-01-01
2023-09-30
0001912461
us-gaap:CommonClassAMember
2024-07-01
2024-09-30
0001912461
us-gaap:CommonClassAMember
2023-07-01
2023-09-30
0001912461
us-gaap:CommonClassAMember
2023-01-01
2023-09-30
0001912461
us-gaap:CommonClassBMember
2024-07-01
2024-09-30
0001912461
us-gaap:CommonClassBMember
2023-07-01
2023-09-30
0001912461
us-gaap:CommonClassBMember
2024-01-01
2024-09-30
0001912461
us-gaap:CommonClassBMember
2023-01-01
2023-09-30
0001912461
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-12-31
0001912461
us-gaap:AdditionalPaidInCapitalMember
2023-12-31
0001912461
us-gaap:RetainedEarningsMember
2023-12-31
0001912461
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2024-01-01
2024-03-31
0001912461
us-gaap:AdditionalPaidInCapitalMember
2024-01-01
2024-03-31
0001912461
us-gaap:RetainedEarningsMember
2024-01-01
2024-03-31
0001912461
2024-01-01
2024-03-31
0001912461
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2024-03-31
0001912461
us-gaap:AdditionalPaidInCapitalMember
2024-03-31
0001912461
us-gaap:RetainedEarningsMember
2024-03-31
0001912461
2024-03-31
0001912461
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2024-04-01
2024-06-30
0001912461
us-gaap:AdditionalPaidInCapitalMember
2024-04-01
2024-06-30
0001912461
us-gaap:RetainedEarningsMember
2024-04-01
2024-06-30
0001912461
2024-04-01
2024-06-30
0001912461
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2024-06-30
0001912461
us-gaap:AdditionalPaidInCapitalMember
2024-06-30
0001912461
us-gaap:RetainedEarningsMember
2024-06-30
0001912461
2024-06-30
0001912461
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2024-07-01
2024-09-30
0001912461
us-gaap:AdditionalPaidInCapitalMember
2024-07-01
2024-09-30
0001912461
us-gaap:RetainedEarningsMember
2024-07-01
2024-09-30
0001912461
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2024-09-30
0001912461
us-gaap:AdditionalPaidInCapitalMember
2024-09-30
0001912461
us-gaap:RetainedEarningsMember
2024-09-30
0001912461
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2022-12-31
0001912461
us-gaap:AdditionalPaidInCapitalMember
2022-12-31
0001912461
us-gaap:RetainedEarningsMember
2022-12-31
0001912461
2022-12-31
0001912461
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-01-01
2023-03-31
0001912461
us-gaap:AdditionalPaidInCapitalMember
2023-01-01
2023-03-31
0001912461
us-gaap:RetainedEarningsMember
2023-01-01
2023-03-31
0001912461
2023-01-01
2023-03-31
0001912461
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-03-31
0001912461
us-gaap:AdditionalPaidInCapitalMember
2023-03-31
0001912461
us-gaap:RetainedEarningsMember
2023-03-31
0001912461
2023-03-31
0001912461
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-04-01
2023-06-30
0001912461
us-gaap:AdditionalPaidInCapitalMember
2023-04-01
2023-06-30
0001912461
us-gaap:RetainedEarningsMember
2023-04-01
2023-06-30
0001912461
2023-04-01
2023-06-30
0001912461
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-06-30
0001912461
us-gaap:AdditionalPaidInCapitalMember
2023-06-30
0001912461
us-gaap:RetainedEarningsMember
2023-06-30
0001912461
2023-06-30
0001912461
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-07-01
2023-09-30
0001912461
us-gaap:AdditionalPaidInCapitalMember
2023-07-01
2023-09-30
0001912461
us-gaap:RetainedEarningsMember
2023-07-01
2023-09-30
0001912461
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-09-30
0001912461
us-gaap:AdditionalPaidInCapitalMember
2023-09-30
0001912461
us-gaap:RetainedEarningsMember
2023-09-30
0001912461
2023-09-30
0001912461
us-gaap:IPOMember
2022-06-28
0001912461
us-gaap:IPOMember
2022-06-28
2022-06-28
0001912461
us-gaap:OverAllotmentOptionMember
2022-06-28
0001912461
us-gaap:OverAllotmentOptionMember
2022-07-20
0001912461
skgr:PartialOverallotmentExerciseMember
2022-07-20
0001912461
skgr:PartialOverallotmentExerciseMember
2022-07-20
2022-07-20
0001912461
us-gaap:OverAllotmentOptionMember
2022-08-09
2022-08-09
0001912461
us-gaap:WarrantMember
us-gaap:PrivatePlacementMember
2024-01-01
2024-09-30
0001912461
us-gaap:WarrantMember
us-gaap:PrivatePlacementMember
2024-09-30
0001912461
skgr:AdditionalPrivatePlacementWarrantsMember
2024-01-01
2024-09-30
0001912461
skgr:AdditionalPrivatePlacementWarrantsMember
2024-09-30
0001912461
skgr:FirstoverfundingLoanMember
2022-06-28
0001912461
skgr:SecondOverfundingLoanMember
2022-07-20
0001912461
skgr:PublicShareholdersMember
2024-09-30
0001912461
skgr:TrustAccountMember
2024-09-30
0001912461
skgr:SponsorMember
2024-01-01
2024-09-30
0001912461
skgr:SponsorMember
2023-10-30
0001912461
2024-03-01
0001912461
skgr:SponsorNoteMember
2024-03-01
0001912461
us-gaap:WarrantMember
us-gaap:CommonClassAMember
2024-03-01
0001912461
skgr:SponsorMember
2024-03-01
2024-03-01
0001912461
2024-09-27
0001912461
us-gaap:WarrantMember
us-gaap:CommonClassAMember
2024-09-27
0001912461
skgr:SecondSponsorMember
2024-09-27
2024-09-27
0001912461
us-gaap:WarrantMember
2024-01-01
2024-09-30
0001912461
us-gaap:CommonClassAMember
2022-12-31
0001912461
us-gaap:CommonClassAMember
2023-01-01
2023-03-31
0001912461
us-gaap:CommonClassAMember
2023-03-31
0001912461
us-gaap:CommonClassAMember
2023-04-01
2023-06-30
0001912461
us-gaap:CommonClassAMember
2023-06-30
0001912461
us-gaap:CommonClassAMember
2023-09-30
0001912461
us-gaap:CommonClassAMember
2023-10-01
2023-12-31
0001912461
us-gaap:CommonClassAMember
2024-01-01
2024-03-31
0001912461
us-gaap:CommonClassAMember
2024-03-31
0001912461
us-gaap:CommonClassAMember
2024-04-01
2024-06-30
0001912461
us-gaap:CommonClassAMember
2024-06-30
0001912461
skgr:PublicWarrantsMember
2024-09-30
0001912461
skgr:RedeemableWarrantMember
2024-09-30
0001912461
skgr:PublicWarrantsMember
us-gaap:CommonClassAMember
2024-09-30
0001912461
skgr:SponsorMember
us-gaap:CommonClassBMember
2021-12-09
2021-12-09
0001912461
skgr:SponsorMember
us-gaap:CommonClassBMember
2021-12-09
0001912461
us-gaap:CommonClassBMember
2022-02-24
2022-02-24
0001912461
us-gaap:CommonClassBMember
2022-05-05
2022-05-05
0001912461
skgr:SponsorMember
us-gaap:CommonClassBMember
2022-05-05
0001912461
skgr:SponsorMember
us-gaap:CommonClassBMember
2024-01-01
2024-09-30
0001912461
skgr:SponsorMember
skgr:FounderSharesMember
2024-09-30
0001912461
skgr:SponsorMember
us-gaap:CommonClassAMember
2024-01-01
2024-09-30
0001912461
skgr:IndependentDirectorNomineesMember
skgr:SponsorMember
us-gaap:CommonClassBMember
2022-02-01
2022-03-31
0001912461
skgr:PrivatePlacementWarrantsMember
skgr:SponsorMember
2024-09-30
0001912461
skgr:PrivatePlacementWarrantsMember
skgr:SponsorMember
2024-01-01
2024-09-30
0001912461
skgr:PrivatePlacementWarrantsMember
skgr:SponsorMember
us-gaap:OverAllotmentOptionMember
2024-09-30
0001912461
skgr:PrivatePlacementWarrantsMember
2024-01-01
2024-09-30
0001912461
skgr:OverfundingLoansMember
skgr:SponsorMember
2022-06-28
0001912461
skgr:SecondOverfundingLoanMember
us-gaap:OverAllotmentOptionMember
2022-07-20
0001912461
skgr:OverfundingLoansMember
skgr:SponsorMember
us-gaap:CommonClassAMember
2024-09-30
0001912461
skgr:WorkingCapitalLoanMember
skgr:SponsorMember
2024-09-30
0001912461
skgr:WorkingCapitalLoanMember
skgr:SponsorMember
2023-12-31
0001912461
skgr:PromissoryNoteMember
skgr:SponsorMember
2023-10-30
0001912461
skgr:PromissoryNoteMember
skgr:SponsorMember
2023-10-30
2023-10-30
0001912461
skgr:PromissoryNoteMember
skgr:FirstSponsorMember
2024-03-01
0001912461
skgr:PromissoryNoteMember
skgr:SponsorMember
2024-09-30
0001912461
skgr:OverfundingLoansMember
skgr:SponsorMember
2024-09-30
0001912461
skgr:PromissoryNoteMember
skgr:SponsorMember
2024-09-27
0001912461
skgr:PromissoryNoteMember
skgr:SponsorMember
us-gaap:CommonClassAMember
2024-09-27
0001912461
skgr:FirstSponsorMember
2024-09-27
2024-09-27
0001912461
skgr:PromissoryNoteMember
skgr:SponsorMember
2023-12-31
0001912461
skgr:ExtensionLoansMember
skgr:SponsorMember
2024-09-30
0001912461
skgr:BusinessCombinationMember
skgr:ExtensionLoansMember
skgr:SponsorMember
2024-09-30
0001912461
skgr:ExtensionLoansMember
2024-09-30
0001912461
skgr:ExtensionLoansMember
2023-12-31
0001912461
skgr:SecretarialAndAdministrationSupportServicesMember
skgr:AffiliateOfSponsorMember
2022-06-23
2022-06-23
0001912461
skgr:AdministrationAndSupportServicesMember
skgr:SponsorMember
2024-07-01
2024-09-30
0001912461
skgr:AdministrationAndSupportServicesMember
skgr:SponsorMember
2024-01-01
2024-09-30
0001912461
skgr:AdministrationAndSupportServicesMember
skgr:SponsorMember
2023-07-01
2023-09-30
0001912461
skgr:AdministrationAndSupportServicesMember
skgr:SponsorMember
2023-01-01
2023-09-30
0001912461
skgr:UnderwriterMember
us-gaap:IPOMember
2024-01-01
2024-09-30
0001912461
2022-07-20
2022-07-20
0001912461
skgr:UnderwriterMember
2022-07-20
0001912461
us-gaap:InvestorMember
us-gaap:CommonClassAMember
2024-01-01
2024-09-30
0001912461
skgr:SponsorMember
us-gaap:CommonClassBMember
2024-01-01
2024-09-30
0001912461
us-gaap:MeasurementInputSharePriceMember
us-gaap:CommonClassAMember
skgr:NonRedemptionAgreementMember
2023-12-27
0001912461
us-gaap:MeasurementInputPriceVolatilityMember
us-gaap:CommonClassAMember
skgr:NonRedemptionAgreementMember
2023-12-27
0001912461
us-gaap:MeasurementInputExpectedTermMember
us-gaap:CommonClassAMember
skgr:NonRedemptionAgreementMember
2023-12-27
0001912461
us-gaap:MeasurementInputRiskFreeInterestRateMember
us-gaap:CommonClassAMember
skgr:NonRedemptionAgreementMember
2023-12-27
0001912461
us-gaap:CommonClassBMember
2022-12-31
0001912461
us-gaap:CommonClassBMember
skgr:FounderSharesMember
2024-09-30
0001912461
us-gaap:OverAllotmentOptionMember
2022-07-20
2022-07-20
0001912461
skgr:PublicWarrantsMember
2023-12-31
0001912461
skgr:PrivatePlacementWarrantsMember
2023-12-31
0001912461
skgr:PrivatePlacementWarrantsMember
2024-09-30
0001912461
skgr:PublicWarrantsMember
2024-01-01
2024-09-30
0001912461
skgr:PublicWarrantsMember
us-gaap:CommonClassAMember
2024-01-01
2024-09-30
0001912461
2023-01-01
2023-12-31
0001912461
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2024-09-30
0001912461
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2024-09-30
0001912461
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2024-09-30
0001912461
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2023-12-31
0001912461
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2023-12-31
0001912461
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2023-12-31
xbrli:shares
iso4217:USD
iso4217:USD
xbrli:shares
xbrli:pure
“In the event that the Company
does not consummate a Business Combination before March 31, 2025, or such earlier date as the Board of Directors may approve in accordance
with the Articles, or such later time as the Members may approve in accordance with the Articles, the Company shall:”
“to modify the substance or
timing of the Company’s obligation to allow redemption in connection with a Business Combination or redeem 100% of the Public Shares
if the Company does not consummate a Business Combination before March 31, 2025, or such earlier date as the Board of Directors may approve
in accordance with the Articles, or such later time as the Members may approve in accordance with the Articles; or”
“In the event that the Company
does not consummate a Business Combination within 27 months of the consummation of the IPO, or such earlier date as the Board of Directors
may approve in accordance with the Articles, or such later time as the Members may approve in accordance with the Articles, the Company
shall:”
“to modify the substance or
timing of the Company’s obligation to allow redemption in connection with a Business Combination or redeem 100% of the Public Shares
if the Company does not consummate a Business Combination within 27 months of the consummation of the IPO, or such earlier date as the
Board of Directors may approve in accordance with the Articles, or such later time as the Members may approve in accordance with the Articles;
or”
It is resolved as a special resolution
that, with effect from the effective time and date of the Company’s Registration Statement on Form 8-A as filed with the United States
Securities and Exchange Commission, the Memorandum and Articles of Association of the Company currently in effect be amended and restated
by the deletion in their entirety and the substitution in their place of the Amended and Restated Memorandum and Articles of Association
annexed hereto.
I, Richard Chin, Chief Executive Officer of the
Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my
knowledge, the Quarterly Report on Form 10-Q of SK Growth Opportunities Corporation (the “Company”) for the quarter ended
September 30, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”) fully complies
with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained
in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
I, Derek Jensen, Chief Financial Officer of the
Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my
knowledge, the Quarterly Report on Form 10-Q of SK Growth Opportunities Corporation (the “Company”) for the quarter ended
September 30, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”) fully complies
with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained
in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company: